Loading...
Diphenhydramine — Export Intelligence Report
2025-Q4 · TransData Nexus
PHARMA TRADE INTELLIGENCE
INDIA EXPORT INTELLIGENCE REPORT
Diphenhydramine
2025-Q4
Comprehensive analysis of India’s diphenhydramine export trade — suppliers, buyers, prices, routes, and every shipment record.
210
Shipments
$4.38M
Trade Value
44
Suppliers
45
Buyers
27
Countries
Scan for online report
Talk to our analyst: +91 95950 78788
https://transdatanexus.com/pharmaceutical/diphenhydramine
01
PART I — OVERVIEW
Executive Summary
At-a-glance KPIs, key findings, and strategic positioning of India’s diphenhydramine trade — 2025-Q4
KEY TAKEAWAY
Diphenhydramine 2025-Q4 exports total $4.4M across 27 countries, with MARKSANS PHARMA LTD commanding 17.9% market share.
TOTAL SHIPMENTS
210
2025-Q4
EXPORT VALUE
$4.4M
FOB USD
TOTAL QUANTITY
87.4M
units shipped
INDIAN SUPPLIERS
44
unique exporters
GLOBAL BUYERS
45
unique importers
DESTINATIONS
27
countries
MEDIAN UNIT PRICE
$0.433
per unit
TOP-5 SHARE
61.0%
of total USD
BRANDED SHARE
39.5%
83 shipments
DOSAGE FORMS
12
product types
6 KEY FINDINGS
1
MARKSANS PHARMA LTD is India's #1 Diphenhydramine exporter with $785.0K (17.9% market share).→ §5, Indian Supplier Rankings
2
Diphenhydramine reached 27 countries, with United States as the top destination ($2.7M).→ §4, Global Destination Map
3
Market concentration is low (HHI: 925) — top 10 suppliers control 82.9% of exports.→ §5, Indian Supplier Rankings
4
93.3% of buyers (42 of 45) source from a single Indian supplier — potential poaching opportunities.→ §6, Global Buyer Rankings
5
Tablet dominates (35.7%) across 12 dosage forms.→ §7, Price Benchmarks
6
26 countries have ≤5 Indian suppliers — easy-entry markets for SME exporters.→ §9, Strategic Opportunities
WHO THIS REPORT IS FOR
S SUPPLIERS (Indian pharma exporters)
- See which buyers your competitors are shipping to, at what price, through which ports
- Identify buyers that are single-sourced (poaching opportunities)
- Benchmark your pricing and catalog vs the Top 25
B BUYERS (global importers)
- Discover which Indian exporters supply this product and what they sell
- Benchmark the price you are paying vs the market median by country and dosage
- Identify alternative suppliers with proven exports to similar destinations
Figure 1.1 MARKSANS PHARMA LTD leads in volume — how do 30 exporters compare on price × volume?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Every bubble is one Indian diphenhydramine exporter. X-axis = shipment count; Y-axis = average unit price; bubble size = total revenue. Dashed lines split at the median — exporters in the top-right (Bulk Leaders) combine high volume with premium pricing.
HOW TO READ THIS REPORT
60 seconds
Scan this page — KPIs, thesis, flagship chart, top findings
5 minutes
Read every Key Takeaway line across §1–§9
30 minutes
Read sections tagged for your role ([S] or [B]) end-to-end
In depth
Drill into §10 for your country · supplier / buyer directories at end
02
PART I — OVERVIEW
About This Report
Data sources, methodology, trust signals, and what this Diphenhydramine report covers
KEY TAKEAWAY
Every figure in this report is grounded in real commercial diphenhydramine trade records. Data comes from official customs filings and public trade sources, runs through a multi-layer quality process, and lands in a clean, consistent report you can rely on.
S FOR SUPPLIERS
Every competitor benchmark, market share figure, and buyer list in this report comes from verified commercial shipments — not surveys or estimates. Use them with confidence when planning your next pitch.
B FOR BUYERS
Every supplier profile, price benchmark, and trade route in this report reflects what that supplier actually ships — real volumes, real destinations, real prices. Use them to qualify and compare Indian diphenhydramine suppliers.
§2.1 Reporting parameters · the scope of this 2025-Q4 Diphenhydramine India trade report
Product scope
Diphenhydramine
All variants merged — branded and generic formulations of diphenhydramine
Time period
2025-Q4
October, November, December 2025 — a single-quarter snapshot
Data sources
Official & public trade records
Government customs filings, public trade databases and licensed commercial feeds
Geography
India origin → global
Indian sea and air ports shipping to destination markets worldwide
Currency
USD (FOB)
Declared Free-on-Board value at the Indian port of loading
Shipments analysed
210
Every commercial diphenhydramine trade record in the period, aggregated and deduplicated
§2.2 Our quality process · Figure 2.1
Figure 2.1 From raw trade records to a clean report — the four quality pillars.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Raw trade data (left) flows through four quality checks — source verification, format standardisation, entity matching, and deduplication — to produce the clean, reliable data (right) behind every chart and table in this report.
§2.3 Trust signals · what you can rely on in the numbers you read
DATA COVERAGE
10M+
Pharmaceutical trade records across the full TransData Nexus platform.
COUNTRIES
150+
Origin and destination countries covered in the global pharma trade database.
DATA ACCURACY
99.9%
Validation rate on core fields — supplier, buyer, product, quantity, value.
UPDATE FREQUENCY
Daily
Platform refresh cadence. This report is a snapshot from the same live data.
§2.4 Limitations · what the data does and does not tell you
WHAT THIS DATA DOES AND DOES NOT SAY
- Prices are at the Indian port of loading (FOB), not the final delivered cost in the destination country. Freight, insurance, import duty and local margin are not included.
- This is a single-quarter snapshot. Multi-quarter trends, year-over-year growth and historical comparisons are available on the full platform.
- A small number of records have incomplete transport mode or destination port fields; these appear blank in the shipment register but are still counted in totals.
- This report is a commercial intelligence tool, not a legal audit. For high-stakes decisions, cross-reference with the underlying trade records via the full platform.
03
PART II — MARKET STRUCTURE
Quarterly Trade Overview
Monthly trends, regional performance, and ranking shifts — 2025-Q4
KEY TAKEAWAY
2025-Q4 followed a mixed: Oct $1.2M, Nov $2.1M, Dec $1.1M. Shipment counts were mixed across the quarter.
S FOR SUPPLIERS
Track which months your competitors were most active, which destinations rose or fell, and whether the Nov dip hit your segment. The bump charts show rank movement — watch for rivals climbing past you.
B FOR BUYERS
Identify whether your current Indian supplier maintained steady shipments through the quarter, or whether they pulled back. Steady suppliers during dips signal reliable partnerships.
1
$1.2M
Oct USD
62 shipments
2
$2.1M
Nov USD
+64.4% MoM
3
$1.1M
Dec USD
-47.5% MoM
4
Mixed
Q4 growth shape
Oct → Nov → Dec
Fig 3.1 Nov rose 64.4% in USD but shipment count kept climbing.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = monthly USD. Orange line = shipment count. When bars drop but line rises, average shipment value fell. Insight: Oct opened at $1.2M, making it the middle month by value.
Fig 3.2 Q4 cumulative USD reached $4.4M.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The curve shows the running total across the quarter. A steeper slope means that month contributed more revenue. Insight: The curve’s steepest section reveals which month drove the most trade value.
Fig 3.3 $803K rise in Nov, $974K decline in Dec.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = absolute monthly value. Red = month-over-month loss; green = gain. Insight: Trade grew steadily across the quarter.
Fig 3.4 Regional breakdown by month — which corridors swung most?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each coloured layer is one destination region. Layer height = USD in that month. Insight: The top region contributed the most, while the smallest region had the least volume.
§3.1 Monthly summary
| Oct | $1.2M | 62 shipments |
| Nov | $2.1M | 95 shipments |
| Dec | $1.1M | 53 shipments |
| Q4 Total | $4.4M | 210 shipments |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 3.5 Top 10 destination countries by monthly USD rank — who’s rising?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a country’s monthly rank. Lines crossing = rank swaps. Insight: United States held #1 throughout the quarter.
Fig 3.6 Top 10 Indian exporters by monthly USD rank.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a supplier’s monthly rank. Flat = stable position; crossing = rank change. Insight: GLAND PHARMA LTD maintained its leading position.
04
PART II — MARKET STRUCTURE
Global Destination Map
Which countries import diphenhydramine from India, how much they buy, and who supplies each market
KEY TAKEAWAY
United States absorbs 61.9% of India’s 2025-Q4 diphenhydramine trade ($2.7M). Beyond the top 10 destinations, 26 countries have fewer than 5 Indian suppliers each — white-space markets where new entrants face minimal competition. Africa has 14 destination countries, the widest regional diversity.
S FOR SUPPLIERS
Use the flow map and lanes table to see which destinations your competitors dominate. For small and mid-size suppliers: look beyond the leading markets — the 26 countries in the long tail have fewer than 5 Indian suppliers each and low competitive barriers.
B FOR BUYERS
Find your country on the map to see how much diphenhydramine India ships to your market, who the top suppliers are, and whether you’re in a concentrated or competitive corridor.
Asia
$91K
2.1% of trade
7 countries · 19 shipments
Americas
$2.8M
64.3% of trade
5 countries · 125 shipments
Africa
$1.5M
33.5% of trade
14 countries · 65 shipments
Oceania
$5K
0.1% of trade
1 countries · 1 shipments
Fig 4.1 United States is the #1 corridor ($2.7M) — 27 flow arcs from India radiate across 4 continents.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The world map shows every country colored by how much Indian diphenhydramine it receives (light = low, dark = high). Orange arcs radiate from India to the top 27 destinations; arc thickness = USD value. All destinations are labeled with country name + USD.
§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers
| # | Destination | Total USD | Ships | #1 Indian supplier | USD | #2 Indian supplier | USD | #3 Indian supplier | USD |
|---|---|---|---|---|---|---|---|---|---|
| 1 | United States | $2.7M | 114 | MARKSANS PHARMA LTD | $772K | GLAND PHARMA LTD | $546K | AVET LIFESCIENCES PVT LTD | $413K |
| 2 | Togo | $564K | 9 | INTACT DRUGS AND PHARMACEUTICLAS PVT LTD | $564K | — | — | — | — |
| 3 | Benin | $364K | 6 | CURE & CARE DRUGS PVT LTD | $364K | — | — | — | — |
| 4 | Sudan | $185K | 12 | SAKAR HEALTHCARE LTD | $185K | — | — | — | — |
| 5 | Republic of the Congo | $123K | 20 | OM LIFE SCIENCE | $123K | — | — | — | — |
| 6 | Ethiopia | $89K | 4 | KOPRAN LTD | $68K | MEDICAMEN BIOTECH LTD | $21K | — | — |
| 7 | Chad | $68K | 1 | ALPHARD PHARMA | $68K | — | — | — | — |
| 8 | Nicaragua | $43K | 1 | CIRON DRUGS AND PHARMACEUTICALS PVT LTD | $43K | — | — | — | — |
| 9 | Kenya | $36K | 1 | CADILA PHARMACEUTICALS LTD | $36K | — | — | — | — |
| 10 | Nigeria | $29K | 2 | SANGHARSH LIFECARE PVT LTD | $29K | — | — | — | — |
Table 4.1 — Top 10 destination countries ranked by trade value, with the largest Indian suppliers for each market.
Fig 4.2 Asia leads at 2.1% of USD — but United States is the single largest market.
Region → country treemap
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Column width = region USD share. Within each column, cells are stacked by country, height = share within region.
§4.2 Destination concentration
61.9%
#1 country share
United States alone
90.1%
Top 5 share
5 of 27 countries
98.7%
Top 15 share
Long tail of 12 countries = 1.3%
HHI 4105
Destination HHI
Highly concentrated
27
Countries served
Global pharma reach from India
14
Africa countries
Widest regional diversity
Source: TransData Nexus trade data platform
05
PART III — WHO’S IN THIS MARKET
Indian Supplier Rankings & Profiles
44 Indian exporters ranked by value — profiles, portfolios, and competitive intelligence
KEY TAKEAWAY
MARKSANS PHARMA LTD ($785.0K, 17.9% share) and INTACT DRUGS AND PHARMACEUTICLAS PVT LTD ($563.6K) together control 30.8% of India’s 2025-Q4 diphenhydramine trade. The top 5 suppliers hold 61.0%. 44 companies shipped at least once.
S FOR SUPPLIERS
Find your rank, your competitors’ ranks, and the gap in USD/share between you. The profile pages show each top supplier’s buyer portfolio, dosage mix and route map — your competitive-intelligence toolkit.
B FOR BUYERS
Find potential Indian diphenhydramine suppliers ranked by size, catalog breadth and destination reach. The profile pages reveal which suppliers have proven trade lanes to your region.
Fig 5.1 MARKSANS PHARMA LTD leads by $221K over INTACT DRUGS AND PHARMACEUTICLAS PVT LTD — top 20 Indian exporters ranked by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian supplier ranked by USD. The (#N) shows their rank by shipment count — mismatches reveal pricing strategy. Insight: OM LIFE SCIENCE is #11 by value but #3 by volume.
Fig 5.2 MARKSANS PHARMA LTD also leads by shipment count (33) but ranking shifts for volume-heavy players
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same suppliers re-ranked by shipment count. The (#N) shows their rank by USD value. Insight: OM LIFE SCIENCE moves from #3 by volume to #11 by value — fewer but higher-value shipments.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — Archetypes & Concentration
How India’s 44 diphenhydramine suppliers split into strategic segments
KEY TAKEAWAY
11 suppliers (25%) generate 85.8% of total trade value. The market splits into four archetypes: Market Leaders, High-Value specialists, Volume players, and a long tail.
Fig 5.3 MARKSANS PHARMA LTD and INTACT DRUGS AND PHARMACEUTICLAS PVT LTD sit in the leaders zone — high volume AND high value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble is one Indian supplier. X-axis = shipment count (log scale); Y-axis = total USD value (log scale); bubble size = revenue. Blue dashed lines split at the median. Market Leaders (top-right) combine high volume with high value. Premium Niche (top-left) ship fewer but higher-value consignments. Volume Players (bottom-right) compete on quantity. Long-Tail (bottom-left) are small or occasional exporters. Conclusion: the log scale reveals clear strategic clusters — use this map to identify where your company sits relative to competitors.
Fig 5.4 25% of suppliers = 85.8% of USD — classic concentration.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Top bar = supplier %, bottom bar = USD %. The gap = market concentration.
Product variety — how many formulations each supplier ships
| # | Supplier | Dosage forms | Countries | USD |
|---|---|---|---|---|
| 1 | MARKSANS PHARMA LTD | 4 | 2 | $785K |
| 2 | SOFTGEL HEALTHCARE PVT LTD | 4 | 1 | $251K |
| 3 | AVET LIFESCIENCES PVT LTD | 2 | 1 | $413K |
| 4 | ELYSIUM PHARMACEUTICALS LTD | 2 | 1 | $242K |
| 5 | TRUECARE BIOMEDIX | 2 | 1 | $128K |
| 6 | INTACT DRUGS AND PHARMACEUTICLAS PVT LTD | 1 | 1 | $564K |
| 7 | GLAND PHARMA LTD | 1 | 1 | $546K |
| 8 | CURE & CARE DRUGS PVT LTD | 1 | 1 | $364K |
| 9 | SAKAR HEALTHCARE LTD | 1 | 1 | $185K |
| 10 | MICRO LABS LTD | 1 | 1 | $154K |
Table 5.1 — The more dosage forms a supplier ships, the more versatile their manufacturing capability.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — India Origin Geography & Concentration
Which Indian cities and states are the diphenhydramine manufacturing hubs
KEY TAKEAWAY
Panipat and Sangareddy together account for $1.1M of India’s 2025-Q4 diphenhydramine trade.
Fig 5.5 Panipat (1 exporters, $564K) and Sangareddy (1 exporters, $546K) are India’s diphenhydramine capitals.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Orange bubbles mark major pharma hub cities; bubble size = USD value. Every hub labeled.
§5.1 Supplier concentration metrics
61.0%
Top 5 share
5 of 44 suppliers
82.9%
Top 10 share
10 of 44 suppliers
85.8%
Top 25% share
11 suppliers = 86% USD
HHI 925
Supplier HHI
Competitive
44
Total suppliers
shipped Diphenhydramine in 2025-Q4
20+ cities
Indian hubs
Panipat and Sangareddy lead
§5.2 Coming next: 1 exporter deep-dive profiles
Each of the top 1 suppliers gets a dedicated 2-page profile with:
- 6 KPI cards — trade value, shipments, countries, buyers, avg ship value, branded share
- Dosage form breakdown — what formulations they ship
- Monthly trend — Oct / Nov / Dec trajectory
- Trade flow map — supplier → country → importer connections
- Buyer portfolio with lock-in analysis
SUPPLIER PROFILES IN THIS REPORT
| #1 | MARKSANS PHARMA LTD | $785K |
#1
EXPORTER PROFILE #1 OF 1
MARKSANS PHARMA LTD
Mumbai · India’s #1 diphenhydramine supplier by USD · 2025-Q4
2025-Q4 USD
$785K
17.9% market share
SHIPMENTS
33
avg $24K/ship
COUNTRIES
2
destination markets
BUYERS
4
3 single-sourced
BRANDED
21%
of shipments
DOSAGE FORMS
4
product types
TOP 2 DESTINATIONS
United States is the #1 market at $772K (98% of trade), followed by Turkey at $13K. 2 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | United States | $772K | 31 | 98.4% |
| 2 | Turkey | $13K | 2 | 1.6% |
MONTHLY TREND
Nov peaked at $408K. Dec was the weakest at $115K.
PRODUCT MIX
Tablet dominates at 83% of trade. Capsule (12.7%) and Chewable Tablet are secondary formulations.
TOP BUYERS · 3/3 LOCKED IN
3 of 3 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| TIME-CAP LABS INC | United States | $611K | ⚠ Locked |
| Undisclosed buyer | United States | $112K | N/A |
| TIME-CAP LABSINC 7 MIC… | United States | $50K | ⚠ Locked |
| ORGANO COMPANY FOR TRA… | Turkey | $13K | ⚠ Locked |
#1
EXPORTER PROFILE #1 OF 1 — TRADE FLOW MAP
MARKSANS PHARMA LTD — Supplier → Country → Importer
2 destination countries, top 5 importers per country
Fig 5.P1.3 United States absorbs $772K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 3 importers per destination.
06
PART III — WHO’S IN THIS MARKET
Global Buyer Rankings & Intelligence
45 importers across 27 countries — who is buying Indian diphenhydramine and how much
KEY TAKEAWAY
The demand side is dramatically more fragmented than supply: the top 25 importers together hold only 77.0% of total USD. 93% of buyers source from a single Indian supplier — a vast pool of lock-in candidates.
S FOR SUPPLIERS
Find the importers buying from your competitors. The rankings reveal who has volume, who pays well, and who sources from multiple Indian suppliers (potential pitch targets).
B FOR BUYERS
See where you rank among global importers of Indian diphenhydramine. Compare your USD and shipment count against peers in your country and dosage segment.
Fig 6.1 TIME-CAP LABS INC is the #1 importer at $611K (14.0%) — top 25 by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one global importer ranked by USD.
Fig 6.2 Re-ranked by shipment count — compare with Fig 6.1 for divergences
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same 25 importers re-ranked by shipment count.
§6.1 Sourcing diversity — how many Indian suppliers does each buyer use?
93%
Single-source
42 buyers rely on exactly 1 Indian supplier
4%
Dual-source
2 buyers use 2 Indian suppliers
0%
Multi-source (3–4)
0 buyers diversified across 3–4
2%
Broad-source (5+)
1 buyers with 5+ Indian suppliers
06
PART III — WHO’S IN THIS MARKET
Single-Source Buyers & Price Benchmark
Lock-in opportunities grouped by country + where each buyer sits on the price spectrum
KEY TAKEAWAY
These importers source diphenhydramine from exactly one Indian supplier. For each one, the table shows the incumbent, price, and dosage.
S FOR SUPPLIERS
This is your target list. Each row is a buyer locked into one competitor. Offer 5–10% better pricing to win the second-source slot.
B FOR BUYERS
If you see your company here, you are fully dependent on one Indian supplier. Consider qualifying a second source.
§6.2 Single-source lock-in by country
United States 5 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| TIME-CAP LABS INC | MARKSANS PHARMA LTD | $611K | $0.710 | Capsule |
| EVERSANA LIFE SCIENCE … | GLAND PHARMA LTD | $546K | $0.460 | Injection |
| AVET PHARMACEUTICALS INC | AVET LIFESCIENCES PV… | $413K | $8.709 | Injection |
| INTL PHARMA PACKAGING … | SOFTGEL HEALTHCARE P… | $175K | $0.725 | softgel capsules |
| CARDINAL 3PL | MICRO LABS LTD | $154K | $12.285 | Injection |
Dominican Republic 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| TO THE ODRER OF AARNEX… | ANH PHARMACEUTICALS … | $2K | $0.213 | Syrup |
| MEDEK PHARMA S.A | VANCE AND HEALTH PHA… | $121.250 | $0.0012 | Syrup |
Benin 1 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| MOUSSA SA | CURE & CARE DRUGS PV… | $364K | $0.436 | — |
Sudan 1 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| AMIPHARMA LABORATORIES… | SAKAR HEALTHCARE LTD | $185K | $0.172 | Syrup |
Republic of the Congo 1 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| R PHARMA | OM LIFE SCIENCE | $123K | $0.373 | Syrup |
§6.3 Price positioning — top 25 importers
| # | Importer | Country | USD | $/ship | Tier |
|---|---|---|---|---|---|
| 1 | TIME-CAP LABS INC | United States | $611K | $24K | Mid |
| 2 | EVERSANA LIFE SCIENC… | United States | $546K | $68K | Premium |
| 3 | AVET PHARMACEUTICALS… | United States | $413K | $52K | Premium |
| 4 | MOUSSA SA | Benin | $364K | $61K | Premium |
| 5 | STRIVE PHARMACEUTICA… | United States | $200K | $29K | Mid |
| 6 | AMIPHARMA LABORATORI… | Sudan | $185K | $15K | Mid |
| 7 | INTL PHARMA PACKAGIN… | United States | $175K | $12K | Budget |
| 8 | CARDINAL 3PL | United States | $154K | $77K | Premium |
| 9 | R PHARMA | Republic of the Congo | $123K | $6K | Budget |
| 10 | CABINET HEALTH P.B.C | United States | $101K | $34K | Mid |
| 11 | SAVE INTERNATIONAL C… | Chad | $68K | $68K | Premium |
| 12 | INTERNATIONAL PHARMA… | United States | $67K | $11K | Budget |
| 13 | SHIELD PHARMACEUTICA… | United States | $61K | $10K | Budget |
| 14 | TIME-CAP LABSINC 7 M… | United States | $50K | $25K | Mid |
| 15 | PIONEER LIFE SCIENCE… | United States | $42K | $21K | Mid |
| 16 | CADILA PHARMACEUTICA… | Kenya | $36K | $36K | Premium |
| 17 | INT L PHARMA PACKAGI… | United States | $29K | $10K | Budget |
| 18 | REALS PHARMACEUTICAL… | Nigeria | $29K | $14K | Budget |
| 19 | SAMJAN GROUP INC | United States | $23K | $23K | Mid |
| 20 | INTIPHARMA S.A | Peru | $22K | $22K | Mid |
| 21 | HAYLEYS CONSUMER PRO… | Sri Lanka | $17K | $17K | Mid |
| 22 | INTL PHARMA PACKAGIN… | United States | $15K | $5K | Budget |
| 23 | HHH PHARMACEUTICALS | United States | $14K | $7K | Budget |
| 24 | PRODOSE INC | United States | $13K | $7K | Budget |
| 25 | ORGANO COMPANY FOR T… | Turkey | $13K | $6K | Budget |
06
PART III — WHO’S IN THIS MARKET
Market Relationship Map
The top 20 × 20 supplier ↔ buyer network as a circular flow diagram
Fig 6.3 MARKSANS PHARMA LTD → TIME-CAP LABS INC is the strongest relationship.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left semicircle = top 20 Indian suppliers; right = top 20 global buyers. Arc length = total USD; colored ribbons = individual relationships, thickness = USD value. Insight: follow the thickest ribbons to identify the dominant trading pairs.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
How Indian diphenhydramine prices vary by supplier, country and dosage form
KEY TAKEAWAY
Diphenhydramine prices span 167816× ($0.0020 → $329.22). The coefficient of variation is 3.66. Dosage form, not destination, is the primary price driver.
S FOR SUPPLIERS
Use the box plot to see where your product sits on the price spectrum. The tornado chart shows exactly where you sit relative to the market median.
B FOR BUYERS
Use this section to benchmark the price you pay against the market. The percentile strip tells you if your current supplier is charging you premium, mid-market or budget rates.
§7.1 Price distribution · Table 7.1
| Statistic | Value | Interpretation |
|---|---|---|
| Min | $0.0020 | Lowest observed unit price |
| P5 | $0.067 | 5th percentile |
| P25 | $0.357 | 25th percentile (Q1) |
| Median | $0.433 | 50th percentile (Q2) |
| P75 | $1.75 | 75th percentile (Q3) |
| P95 | $152.05 | 95th percentile |
| Max | $329.22 | Highest observed unit price |
| Mean | $16.31 | Arithmetic average |
| CV | 366% | Coefficient of variation (std/mean) |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 7.1 ELYSIUM PHARMACEUTICALS LTD prices at $270.37/unit vs market median $0.433.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar shows one supplier’s average unit price relative to the market median (dashed line). Red = above median (premium), green = below (budget).
COMMODITY KINGS
high volume · low unit price
Bulk API/tablet. Largest absolute USD despite lowest per-unit prices. e.g. INTACT DRUGS AND Sourcing: best for cost-driven procurement.
BULK LEADERS
high volume · premium price
Branded-generic leaders, above-median pricing. e.g. MARKSANS PHARMA LTD Sourcing: hardest to displace; compete on relationship.
LONG-TAIL
low volume · low unit price
Spot/opportunistic players. e.g. ALPHARD PHARMA Sourcing: first to approach for new tenders.
PREMIUM NICHE
low volume · premium price
Sterile injectables and infusions. Hospital-grade. e.g. MICRO LABS LTD Sourcing: expect 10× price vs tablet.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
Outlier forensics and the procurement cheat sheet — what to expect to pay by country × dosage
KEY TAKEAWAY
Extreme prices are real: the highest are specialty/sterile formulations; the lowest are bulk API. The cheat sheet matrix is the take-home reference for procurement teams.
§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices
↑ TOP 10 HIGHEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Nov 2025 | KOPRAN LTD | Ethiopia | Capsule | 32 | $68K | $2K | Specialty / small-batch |
| Nov 2025 | ELYSIUM PHARMACE… | United States | Capsule | 59 | $39K | $663.11 | Specialty / small-batch |
| Oct 2025 | ELYSIUM PHARMACE… | United States | Capsule | 52 | $17K | $329.22 | Specialty / small-batch |
| Nov 2025 | ELYSIUM PHARMACE… | United States | Capsule | 25 | $8K | $327.07 | Specialty / small-batch |
| Dec 2025 | ELYSIUM PHARMACE… | United States | Capsule | 103 | $33K | $322.34 | Specialty / small-batch |
| Nov 2025 | ELYSIUM PHARMACE… | United States | Tablet | 100 | $26K | $263.51 | Specialty / small-batch |
| Dec 2025 | ELYSIUM PHARMACE… | United States | Tablet | 200 | $52K | $262.25 | Specialty / small-batch |
| Nov 2025 | ELYSIUM PHARMACE… | United States | Tablet | 90 | $22K | $248.06 | Specialty / small-batch |
| Nov 2025 | ELYSIUM PHARMACE… | United States | Tablet | 100 | $24K | $243.85 | Specialty / small-batch |
| Nov 2025 | ELYSIUM PHARMACE… | United States | Tablet | 20 | $5K | $241.57 | Specialty / small-batch |
↓ TOP 10 LOWEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Dec 2025 | VANCE AND HEALTH… | Dominican Republic | Syrup | 50K | $60.50 | $0.0012 | |
| Dec 2025 | VANCE AND HEALTH… | Dominican Republic | Syrup | 50K | $60.75 | $0.0012 | |
| Oct 2025 | TRUECARE BIOMEDIX | United States | Tablet | 7.5M | $15K | $0.0020 | Bulk generic tablet |
| Oct 2025 | TRUECARE BIOMEDIX | United States | Tablet | 7.5M | $15K | $0.0020 | Bulk generic tablet |
| Dec 2025 | TRUECARE BIOMEDIX | United States | Tablet | 35.0M | $71K | $0.0020 | Bulk generic tablet |
| Nov 2025 | OCEAN HEALTHCARE… | United States | Tablet | 9.8M | $23K | $0.0023 | Bulk generic tablet |
| Nov 2025 | GLOBELA PHARMA P… | United States | Tablet | 12.0M | $32K | $0.0026 | Bulk generic tablet |
| Dec 2025 | CUIDADO MEDICO P… | Mauritius | Cream | 140 | $0.464 | $0.0033 | Small sample / trial shipment |
| Oct 2025 | TRUECARE BIOMEDIX | United States | Capsule | 2.5M | $9K | $0.0034 | Bulk volume discount |
| Dec 2025 | TRUECARE BIOMEDIX | United States | Capsule | 5.5M | $19K | $0.0035 | Bulk volume discount |
§7.3 Procurement cheat sheet — median USD/unit by country × dosage
Fig 7.2 Median unit price by country × dosage form — darker cells = higher prices.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each cell shows the median price per unit for that country-dosage combination. Dark blue = expensive, light = cheap. Blank cells = no shipments in that combination.
NEGOTIATION RANGE
Use each cell value as the anchor price. Typical dynamics:
- Budget buyer: anchor − 10–15% (floor = cost + freight)
- Mid-market: anchor ± 5–10%
- Premium/tender: anchor + 10–25% (regulated, quality premium)
- Injection/infusion: always 4–10× the tablet price
KEY TAKEAWAYS
- Dosage form is the #1 price driver, not destination
- Light cells = easy-entry markets for small suppliers
- Dark cells = premium markets requiring regulatory investment
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Which Indian ports ship diphenhydramine, which global ports receive it, and which corridors are high-value vs bulk
KEY TAKEAWAY
Diphenhydramine leaves India through 19+ ports. The top 5 (NHAVA SHEVA SEA (JNPT), AHMEDABAD ICD, PATPARGANJ ICD) handle 78.5% of total USD. SEA moves 48% of shipments.
S FOR SUPPLIERS
Use the dumbbell to classify your port as high-value hub or bulk workhorse. Note the short-sea routes — Bangladesh, Sri Lanka, Myanmar and East Africa are the easiest logistics corridors for first-time exporters.
B FOR BUYERS
Use the destination port ranking to find which Indian ports serve your market. The lead-time estimates tell you what transit time to expect.
Fig 8.1 NHAVA SHEVA SEA (JNPT) handles $1.3M — top 19 Indian origin ports by trade value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian port. Bar length = USD value. The largest ports handle the majority of trade.
Fig 8.2 New York is the #1 global destination port — top 25 by USD value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one destination port worldwide. Bar length = USD value received from India.
§8.1 Reference transit times for key India → global corridors
| Route | Mode | Transit time | Notes |
|---|---|---|---|
| NHAVA SHEVA SEA (JNPT) → US East Coast | Sea | 22–28 days | Via Suez; 2–3 transshipments typical |
| NHAVA SHEVA SEA (JNPT) → Lagos (Nigeria) | Sea | 18–24 days | Direct liner service available |
| MUMBAI AIR (SAHAR) → New York JFK | Air | 3–5 days | Direct cargo; cold-chain available |
| MUNDRA SEA → Rotterdam | Sea | 20–26 days | Via Suez; Hamburg also served |
| HYDERABAD AIR → London Heathrow | Air | 2–4 days | Pharma-grade cargo corridor |
| CHENNAI SEA → Chittagong (Bangladesh) | Sea | 7–12 days | Short-sea route; high frequency |
| RAXAUL → Birgunj (Nepal) | Road | 1–2 days | Land border crossing |
| NHAVA SHEVA SEA (JNPT) → Mombasa (Kenya) | Sea | 14–20 days | Direct or via Colombo hub |
Table 8.1 — Reference times based on standard shipping corridors. Air = 2–5 days; sea = 7–28 days; road = 1–2 days. Add 3–7 days for customs clearance at destination.
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Trade corridors — origin port to mode of transport to destination region
KEY TAKEAWAY
SEA dominates at 48% of shipments. The alluvial traces every dollar from Indian origin port through transport mode to destination region.
SEA
$1.9M
44.3% of USD · 48.1% of ships
ICD
$1.9M
43.2% of USD · 40.0% of ships
AIR
$547K
12.5% of USD · 11.9% of ships
Fig 8.3 The dominant corridor is NHAVA SHEVA SEA (JNPT) → Sea → N. America ($1.1M).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian origin ports. Middle = transport mode. Right = destination region. Ribbon thickness = USD value; color = mode. Follow the thickest ribbons to find the highest-value corridors.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market concentration, supply-chain risk, and the dependency patterns that signal where to act
KEY TAKEAWAY
Republic of the Congo is the most concentrated destination (HHI 10000, 1 suppliers). United States is the most competitive (HHI 1683).
S FOR SUPPLIERS
The HHI barbell shows where competitors have locked up a market (concentrated = poaching opportunity) vs where you must compete on quality (fragmented). The slope chart reveals who is gaining ground.
B FOR BUYERS
The HHI barbell tells you whether your country has enough supplier options. If concentrated (red zone), you have fewer alternatives.
Fig 9.1 Republic of the Congo (HHI 10,000) is the most concentrated — United States (HHI 1,683) is the most competitive.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
What is HHI? The Herfindahl-Hirschman Index measures how concentrated a market is among its suppliers. It ranges from 0 to 10,000. Below 1,500 (green zone) = many suppliers compete openly — healthy, competitive market with low risk. 1,500–2,500 (yellow zone) = a few suppliers hold significant share — moderate concentration. Above 2,500 (red zone) = one or two suppliers dominate the market — high risk for buyers who may lose supply, and hard to break into for new suppliers. Conclusion: 19 of 20 destination markets are concentrated (red zone). 0 are competitive (green zone). Buyers in red-zone markets should urgently qualify a second Indian supplier to reduce dependency risk.
§9.1 Single-source dependencies
| Buyer | Country | Sole supplier | USD | Ships | Risk |
|---|---|---|---|---|---|
| TIME-CAP LABS INC | United States | MARKSANS PHARMA … | $611K | 25 | CRITICAL |
| EVERSANA LIFE SCIENC… | United States | GLAND PHARMA LTD | $546K | 8 | CRITICAL |
| AVET PHARMACEUTICALS… | United States | AVET LIFESCIENCE… | $413K | 8 | HIGH |
| MOUSSA SA | Benin | CURE & CARE DRUG… | $364K | 6 | HIGH |
| AMIPHARMA LABORATORI… | Sudan | SAKAR HEALTHCARE… | $185K | 12 | HIGH |
| INTL PHARMA PACKAGIN… | United States | SOFTGEL HEALTHCA… | $175K | 15 | HIGH |
| CARDINAL 3PL | United States | MICRO LABS LTD | $154K | 2 | HIGH |
| R PHARMA | Republic of the Congo | OM LIFE SCIENCE | $123K | 20 | HIGH |
Conclusion: 42 buyers depend on exactly one Indian supplier, representing $3.2M in trade. 2 are rated CRITICAL — if their sole supplier fails, they have no backup. For suppliers: each row is a competitor’s locked-in customer you can target.
§9.2 Multi-source resilience
| Buyer | Country | Suppliers | USD | Dominant | Resilience |
|---|
Conclusion: 0 of these buyers have HIGH resilience (3+ active suppliers). These are the hardest accounts to win but safest partners for long-term contracts.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market entry playbook and risk landscape by destination country
KEY TAKEAWAY
15 target markets with specific entry approaches. Large suppliers: focus on regulated Tier 1 markets. Small/mid-size: start with Tier 2–3 (low barrier, growing demand).
§9.3 Sourcing recommendations · Table 9.1
| Country | Tier | Lead | Price | Risk | Entry approach |
|---|---|---|---|---|---|
| United States | Tier 2 (competitive) | 3–5 days (air) | $1–$10/unit | MEDIUM | Price + relationship |
| Togo | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| Benin | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| Sudan | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| Republic of the Congo | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| Ethiopia | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Chad | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| Nicaragua | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| Kenya | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| Nigeria | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| United Arab Emirates | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Peru | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Turkey | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| Dominican Republic | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Guyana | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
For suppliers: Tier 1 markets (US, UK, France) require regulatory investment but offer premium pricing. Tier 3 markets (emerging) have low barriers — ideal for first-time exporters. For buyers: Use the price band and lead time to benchmark your current supplier’s terms.
Fig 9.2 0 markets in the Growth Opportunity zone (competitive + growing). 11 in Fragile Dependency (concentrated + shrinking).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble = one destination. X-axis = HHI (concentration). Y-axis = growth %. Bubble size = USD. Green zone (top-left) = Growth Opportunity — competitive markets that are growing, best for new entrants. Red zone (bottom-right) = Fragile Dependency — concentrated + shrinking, high supply-chain risk. Conclusion: Key markets are the top growth opportunities.
09
PART V — ACTION
Action Plan & Easy-Entry Markets
12 prioritised actions + 15 low-competition destination countries for small & mid-size suppliers
KEY TAKEAWAY
Quick Wins: execute this quarter. Big Bets: plan for next 6–12 months. Plus 15 countries with ≤5 Indian suppliers — the best entry points for SMEs.
S
FOR SUPPLIERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A1 | Pitch top single-source buyer in United States | This Q | HIGH |
| A2 | Offer alternative to top multi-source buyer | This Q | HIGH |
| A3 | Audit Republic of the Congo lock-ins (HHI 10000) | This Q | MED |
| A5 | Enter Togo (1 suppliers) | This Q | HIGH |
| A6 | Enter Sudan (1 suppliers) | This Q | MED |
| A8 | Build Togo distribution | 6–12m | HIGH |
| A9 | Bundle injection/infusion catalog for premium markets | 6–12m | MED |
B
FOR BUYERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A4 | Monitor rising exporters (SAKAR HEALTHCARE) | This Q | MED |
| A7 | Register for United States tenders | 6–12m | HIGH |
| A10 | Track quarterly HHI shifts across key destinations | This Q | LOW |
| A11 | Map competitor buyer portfolios quarterly | This Q | MED |
| A12 | Qualify second source for single-source buyers | This Q | MED |
§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers
| # | Country | Region | Suppliers | Q4 USD | Growth | Barrier | Why this is easy |
|---|---|---|---|---|---|---|---|
| 1 | Togo | Africa | 1 | $564K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 2 | Sudan | Africa | 1 | $185K | +193.5% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 3 | Benin | Africa | 1 | $364K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 4 | Guyana | Other | 2 | $19K | +1617.5% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 5 | Dominican Republic | Other | 3 | $19K | +705.4% | LOW | Growing 705% with only 3 competitors |
| 6 | Republic of the Congo | Africa | 1 | $123K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 7 | Ethiopia | Africa | 2 | $89K | -100% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 8 | Chad | Africa | 1 | $68K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 9 | Nicaragua | Other | 1 | $43K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 10 | Kenya | Africa | 1 | $36K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 11 | Nigeria | Africa | 1 | $29K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 12 | United Arab Emirates | Other | 2 | $29K | -100% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 13 | Peru | Other | 1 | $22K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 14 | Turkey | Other | 2 | $22K | -100% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 15 | Afghanistan | Asia | 2 | $17K | -100% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
This report covers 210 2025-Q4 Diphenhydramine shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/diphenhydramine
10
PART VI — EVIDENCE REGISTER
Comprehensive Shipment Records by Region
Authoritative source behind all analytics in this report — every shipment appears exactly once
KEY TAKEAWAY
This section contains every one of the 210 2025-Q4 diphenhydramine shipments, organised by Region → Exporter → Shipment rows. No row is duplicated.
S FOR SUPPLIERS
Jump to any destination country to see exactly who your competitors ship to, what they charge, through which port, and how often.
B FOR BUYERS
Jump to your country to see every Indian diphenhydramine shipment that arrived in 2025-Q4: supplier, price, dosage, port.
§10.1 Global totals
SHIPMENTS
210
across all regions
TOTAL USD
$4.38M
2025-Q4 FOB value
UNITS
87.4M
tablets, capsules, etc.
SUPPLIERS
44
Indian exporters
BUYERS
45
global importers
COUNTRIES
27
destinations
§10.2 Regional breakdown
§10.3 Key insights from the data
Africa is the largest region at $1.47M (33.5%), spanning 14 countries.
44 Indian suppliers shipped to 45 buyers across 27 countries — average shipment value $21K.
Top 0 markets: .
Every row below is real customs data — date, importer, dosage, brand, quantity, unit price, total USD, origin port, destination port, and transport mode.
§10.4 How to read a country page
1
6 KPI cards — shipments, USD, qty, exporters, importers, avg unit price.
2
4 mini-lists — top exporters, importers, dosages, monthly trend.
3
Shipment register — every row grouped by exporter. No row is duplicated or omitted.
10
PART VI — DRILL-DOWN · AFRICA
Region: Africa
14 countries · 65 shipments · $1.47M · 14 Indian suppliers · 12 buyers
SHIPMENTS
65
USD
$1.47M
COUNTRIES
14
SUPPLIERS
14
BUYERS
12
HHI
2,376
moderate
Top 14 destination countries in Africa
1
Togo (38.4%)
$564K
2
Benin (24.8%)
$364K
3
Sudan (12.6%)
$185K
4
Republic of the Congo (8.4%)
$123K
5
Ethiopia (6.0%)
$89K
6
Chad (4.6%)
$68K
7
Kenya (2.5%)
$36K
8
Nigeria (2.0%)
$29K
9
DR Congo (0.2%)
$3K
10
Sierra Leone (0.2%)
$3K
11
Liberia (0.1%)
$1K
12
Mozambique (0.1%)
$964.85
13
Mauritius (0.1%)
$857.63
14
Seychelles (0.0%)
$84.28
Top 14 Indian suppliers into Africa
1
INTACT DRUGS AND PHARMACEUTICLAS PVT LTD
$564K
2
CURE & CARE DRUGS PVT LTD
$364K
3
SAKAR HEALTHCARE LTD
$185K
4
OM LIFE SCIENCE
$123K
5
ALPHARD PHARMA
$68K
6
KOPRAN LTD
$68K
7
CADILA PHARMACEUTICALS LTD
$36K
8
SANGHARSH LIFECARE PVT LTD
$29K
9
MEDICAMEN BIOTECH LTD
$21K
10
SYNCOM FORMULATIONS (INDIA) LTD
$4K
11
SHALINA LABORATORIES PVT LTD
$3K
12
GLOBAL PHARMA HEALTHCARE PVT LTD
$964.85
13
CUIDADO MEDICO PVT LTD
$857.63
14
NALIINI.R.EXPORT PVT LTD
$84.28
Top 11 Africa importers
1
MOUSSA SA · Benin
$364K
2
AMIPHARMA LABORATORIES LTD · Sudan
$185K
3
R PHARMA · Republic of the Congo
$123K
4
SAVE INTERNATIONAL CONCEPT SARL · Chad
$68K
5
CADILA PHARMACEUTICALS (E.A.) LTD · Kenya
$36K
6
REALS PHARMACEUTICALS LTD · Nigeria
$29K
7
SHALINA HEALTHCARE SARL · DR Congo
$3K
8
DASYN PHARMACEUTICAL (SL) LTD · Sierra Leone
$2K
9
DEVESH PHARMACEUTICALS INC · Liberia
$1K
10
CUREPHARM LTD · Mauritius
$857.63
11
CENTRAL POINT PHARMACY · Seychelles
$84.28
Top 9 dosage forms
1
Syrup
$877K
2
Unknown
$220K
3
Tablet
$208K
4
Other
$68K
5
Capsule
$68K
6
Solution
$24K
7
Cream
$857.63
8
Ointment
$82.20
9
Injection
$2.08
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 8 | $130K | $16K |
| Nov | 40 | $925K | $23K |
| Dec | 17 | $411K | $24K |
Shipment register · 65 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — INTACT DRUGS AND PHARMACEUTICLAS PVT LTD · 9 shipments · $564K | |||||||||||
| 1 | Nov 2025 | UNLISTED BUYER | Togo | Syrup | 178.0K | PCS | $0.350 | $62K | PATPARGANJ ICD | LOME | ICD |
| 2 | Nov 2025 | UNLISTED BUYER | Togo | Syrup | 178.0K | PCS | $0.350 | $62K | PATPARGANJ ICD | LOME | ICD |
| 3 | Nov 2025 | UNLISTED BUYER | Togo | Syrup | 178.0K | PCS | $0.350 | $62K | PATPARGANJ ICD | LOME | ICD |
| 4 | Nov 2025 | UNLISTED BUYER | Togo | Syrup | 178.0K | PCS | $0.350 | $62K | PATPARGANJ ICD | LOME | ICD |
| 5 | Nov 2025 | UNLISTED BUYER | Togo | Syrup | 178.0K | PCS | $0.350 | $62K | PATPARGANJ ICD | LOME | ICD |
| 6 | Nov 2025 | UNLISTED BUYER | Togo | Syrup | 178.0K | PCS | $0.350 | $62K | PATPARGANJ ICD | LOME | ICD |
| 7 | Dec 2025 | UNLISTED BUYER | Togo | Syrup | 176.5K | PCS | $0.357 | $63K | PATPARGANJ ICD | LOME | ICD |
| 8 | Dec 2025 | UNLISTED BUYER | Togo | Syrup | 178.0K | PCS | $0.357 | $64K | PATPARGANJ ICD | LOME | ICD |
| 9 | Dec 2025 | UNLISTED BUYER | Togo | Syrup | 178.0K | PCS | $0.357 | $64K | PATPARGANJ ICD | LOME | ICD |
| SUPPLIER #2 — CURE & CARE DRUGS PVT LTD · 6 shipments · $364K | |||||||||||
| 10 | Nov 2025 | MOUSSA SA | Benin | 168.6K | NOS | $0.433 | $73K | AHMEDABAD ICD | Cotonou | ICD | |
| 11 | Nov 2025 | MOUSSA SA | Benin | 168.5K | NOS | $0.433 | $73K | AHMEDABAD ICD | Cotonou | ICD | |
| 12 | Nov 2025 | MOUSSA SA | Benin | Tablet | 81.2K | NOS | $0.434 | $35K | AHMEDABAD ICD | COTONOU | ICD |
| 13 | Nov 2025 | MOUSSA SA | Benin | Tablet | 79.3K | NOS | $0.434 | $34K | AHMEDABAD ICD | COTONOU | ICD |
| 14 | Nov 2025 | MOUSSA SA | Benin | 168.6K | NOS | $0.441 | $74K | AHMEDABAD ICD | COTONOU | ICD | |
| 15 | Dec 2025 | MOUSSA SA | Benin | Tablet | 168.1K | NOS | $0.439 | $74K | AHMEDABAD ICD | COTONOU | ICD |
| SUPPLIER #3 — SAKAR HEALTHCARE LTD · 12 shipments · $185K | |||||||||||
| 16 | Oct 2025 | AMIPHARMA LABORATORIES LTD | Sudan | Syrup | 175.3K | VLS | $0.170 | $30K | AHMEDABAD ICD | PORT SUDAN | ICD |
| 17 | Oct 2025 | AMIPHARMA LABORATORIES LTD | Sudan | Syrup | 58.4K | NOS | $0.169 | $10K | AHMEDABAD ICD | PORT SUDAN | ICD |
| 18 | Nov 2025 | AMIPHARMA LABORATORIES LTD | Sudan | Syrup | 116.8K | NOS | $0.171 | $20K | AHMEDABAD ICD | PORT SUDAN | ICD |
| 19 | Nov 2025 | AMIPHARMA LABORATORIES LTD | Sudan | Syrup | 19.5K | NOS | $0.160 | $3K | AHMEDABAD ICD | PORT SUDAN | ICD |
| 20 | Nov 2025 | AMIPHARMA LABORATORIES LTD | Sudan | Syrup | 29.2K | NOS | $0.179 | $5K | AHMEDABAD ICD | PORT SUDAN | ICD |
| 21 | Dec 2025 | AMIPHARMA LABORATORIES LTD | Sudan | Syrup | 87.9K | NOS | $0.182 | $16K | AHMEDABAD ICD | PORT SUDAN | ICD |
| 22 | Dec 2025 | AMIPHARMA LABORATORIES LTD | Sudan | Syrup | 87.6K | NOS | $0.165 | $14K | AHMEDABAD ICD | PORT SUDAN | ICD |
| 23 | Dec 2025 | AMIPHARMA LABORATORIES LTD | Sudan | Syrup | 87.8K | NOS | $0.182 | $16K | AHMEDABAD ICD | PORT SUDAN | ICD |
| 24 | Dec 2025 | AMIPHARMA LABORATORIES LTD | Sudan | Syrup | 87.7K | NOS | $0.165 | $14K | AHMEDABAD ICD | PORT SUDAN | ICD |
| 25 | Dec 2025 | AMIPHARMA LABORATORIES LTD | Sudan | Syrup | 58.4K | NOS | $0.172 | $10K | AHMEDABAD ICD | PORT SUDAN | ICD |
| 26 | Dec 2025 | AMIPHARMA LABORATORIES LTD | Sudan | Syrup | 116.8K | NOS | $0.174 | $20K | AHMEDABAD ICD | PORT SUDAN | ICD |
| 27 | Dec 2025 | AMIPHARMA LABORATORIES LTD | Sudan | Syrup | 146.0K | NOS | $0.174 | $25K | AHMEDABAD ICD | PORT SUDAN | ICD |
| SUPPLIER #4 — OM LIFE SCIENCE · 20 shipments · $123K | |||||||||||
| 28 | Nov 2025 | R PHARMA | Republic of the Congo | Syrup | 19.9K | PCS | $0.375 | $7K | SONEPAT ICD | MATADI | ICD |
| 29 | Nov 2025 | R PHARMA | Republic of the Congo | Syrup | 19.9K | PCS | $0.375 | $7K | SONEPAT ICD | MATADI | ICD |
| 30 | Nov 2025 | R PHARMA | Republic of the Congo | Syrup | 19.9K | PCS | $0.375 | $7K | SONEPAT ICD | MATADI | ICD |
| 31 | Nov 2025 | R PHARMA | Republic of the Congo | Syrup | 19.9K | PCS | $0.375 | $7K | SONEPAT ICD | MATADI | ICD |
| 32 | Nov 2025 | R PHARMA | Republic of the Congo | Syrup | 300 | PCS | $0.375 | $112.55 | SONEPAT ICD | MATADI | ICD |
| 33 | Nov 2025 | R PHARMA | Republic of the Congo | Syrup | 2.3K | PCS | $0.375 | $862.92 | SONEPAT ICD | MATADI | ICD |
| 34 | Nov 2025 | R PHARMA | Republic of the Congo | Syrup | 19.9K | PCS | $0.373 | $7K | SONEPAT ICD | MATADI | ICD |
| 35 | Nov 2025 | R PHARMA | Republic of the Congo | Syrup | 19.9K | PCS | $0.373 | $7K | SONEPAT ICD | MATADI | ICD |
| 36 | Nov 2025 | R PHARMA | Republic of the Congo | Syrup | 19.9K | PCS | $0.373 | $7K | SONEPAT ICD | MATADI | ICD |
| 37 | Nov 2025 | R PHARMA | Republic of the Congo | Syrup | 19.9K | PCS | $0.373 | $7K | SONEPAT ICD | MATADI | ICD |
| 38 | Nov 2025 | R PHARMA | Republic of the Congo | Syrup | 100 | PCS | $0.373 | $37.26 | SONEPAT ICD | Matadi | ICD |
| 39 | Nov 2025 | R PHARMA | Republic of the Congo | Syrup | 8.7K | PCS | $0.373 | $3K | SONEPAT ICD | Matadi | ICD |
| 40 | Nov 2025 | R PHARMA | Republic of the Congo | Syrup | 19.9K | PCS | $0.373 | $7K | SONEPAT ICD | Matadi | ICD |
| 41 | Nov 2025 | R PHARMA | Republic of the Congo | Syrup | 19.9K | PCS | $0.373 | $7K | SONEPAT ICD | Matadi | ICD |
| 42 | Nov 2025 | R PHARMA | Republic of the Congo | Syrup | 19.9K | PCS | $0.373 | $7K | SONEPAT ICD | Matadi | ICD |
| 43 | Nov 2025 | R PHARMA | Republic of the Congo | Syrup | 19.9K | PCS | $0.373 | $7K | SONEPAT ICD | Matadi | ICD |
| 44 | Nov 2025 | R PHARMA | Republic of the Congo | Syrup | 19.9K | PCS | $0.373 | $7K | SONEPAT ICD | Matadi | ICD |
| 45 | Nov 2025 | R PHARMA | Republic of the Congo | Syrup | 19.9K | PCS | $0.373 | $7K | SONEPAT ICD | Matadi | ICD |
| 46 | Nov 2025 | R PHARMA | Republic of the Congo | Syrup | 19.9K | PCS | $0.373 | $7K | SONEPAT ICD | Matadi | ICD |
| 47 | Nov 2025 | R PHARMA | Republic of the Congo | Syrup | 19.9K | PCS | $0.373 | $7K | SONEPAT ICD | Matadi | ICD |
| SUPPLIER #5 — ALPHARD PHARMA · 1 shipments · $68K | |||||||||||
| 48 | Oct 2025 | SAVE INTERNATIONAL CONCEPT SARL | Chad | Other | 170.0K | NOS | $0.401 | $68K | NHAVA SHEVA SEA (JNPT) | Apapa | SEA |
| SUPPLIER #6 — KOPRAN LTD · 1 shipments · $68K | |||||||||||
| 49 | Nov 2025 | UNLISTED BUYER | Ethiopia | Capsule | 32 | THD | $2K | $68K | NHAVA SHEVA SEA (JNPT) | Djibouti | SEA |
| SUPPLIER #7 — CADILA PHARMACEUTICALS LTD · 1 shipments · $36K | |||||||||||
| 50 | Nov 2025 | CADILA PHARMACEUTICALS (E.A.) LTD | Kenya | Tablet | 71.3K | NOS | $0.512 | $36K | AHMEDABAD ICD | MOMBASA | ICD |
| SUPPLIER #8 — SANGHARSH LIFECARE PVT LTD · 2 shipments · $29K | |||||||||||
| 51 | Dec 2025 | REALS PHARMACEUTICALS LTD | Nigeria | Tablet | 8.7K | NOS | $2.50 | $22K | AHMEDABAD ICD | APAPA | ICD |
| 52 | Dec 2025 | REALS PHARMACEUTICALS LTD | Nigeria | Tablet | 4.5K | NOS | $1.53 | $7K | AHMEDABAD ICD | APAPA | ICD |
| SUPPLIER #9 — MEDICAMEN BIOTECH LTD · 3 shipments · $21K | |||||||||||
| 53 | Oct 2025 | UNLISTED BUYER | Ethiopia | Solution | 30.0K | NOS | $0.311 | $9K | NHAVA SHEVA SEA (JNPT) | Djibouti | SEA |
| 54 | Oct 2025 | UNLISTED BUYER | Ethiopia | Solution | 30.0K | NOS | $0.307 | $9K | NHAVA SHEVA SEA (JNPT) | Djibouti | SEA |
| 55 | Nov 2025 | UNLISTED BUYER | Ethiopia | Solution | 8.0K | NOS | $0.307 | $2K | NHAVA SHEVA SEA (JNPT) | Djibouti | SEA |
| SUPPLIER #10 — SYNCOM FORMULATIONS (INDIA) LTD · 4 shipments · $4K | |||||||||||
| 56 | Nov 2025 | DASYN PHARMACEUTICAL (SL) LTD | Sierra Leone | Solution | 98 | NOS | $18.75 | $2K | PITHAMPUR ICD | FREETOWN | ICD |
| 57 | Nov 2025 | DEVESH PHARMACEUTICALS INC | Liberia | Solution | 48 | NOS | $22.89 | $1K | PITHAMPUR ICD | MONROVIA | ICD |
| 58 | Dec 2025 | UNLISTED BUYER | Sierra Leone | Syrup | 60 | NOS | $21.51 | $1K | PITHAMPUR ICD | FREETOWN | ICD |
| 59 | Dec 2025 | UNLISTED BUYER | Sierra Leone | Syrup | 1 | NOS | $7.96 | $7.96 | PITHAMPUR ICD | FREETOWN | ICD |
| SUPPLIER #11 — SHALINA LABORATORIES PVT LTD · 1 shipments · $3K | |||||||||||
| 60 | Oct 2025 | SHALINA HEALTHCARE SARL | DR Congo | Syrup | 15.5K | NOS | $0.214 | $3K | NHAVA SHEVA SEA (JNPT) | Matadi | SEA |
| SUPPLIER #12 — GLOBAL PHARMA HEALTHCARE PVT LTD · 1 shipments · $964.85 | |||||||||||
| 61 | Nov 2025 | UNLISTED BUYER | Mozambique | Syrup | 1.9K | NOS | $0.499 | $964.85 | KATTUPALLI PORT SEA | Maputo | SEA |
| SUPPLIER #13 — CUIDADO MEDICO PVT LTD · 2 shipments · $857.63 | |||||||||||
| 62 | Dec 2025 | CUREPHARM LTD | Mauritius | Cream | 2.9K | NOS | $0.298 | $857.16 | AHMEDABAD ICD | PORT LOUIS | ICD |
| 63 | Dec 2025 | CUREPHARM LTD | Mauritius | Cream | 140 | NOS | $0.0033 | $0.464 | AHMEDABAD ICD | PORT LOUIS | ICD |
| SUPPLIER #14 — NALIINI.R.EXPORT PVT LTD · 2 shipments · $84.28 | |||||||||||
| 64 | Oct 2025 | CENTRAL POINT PHARMACY | Seychelles | Injection | 3 | NOS | $0.694 | $2.08 | CHENNAI AIR | MAHE ISLAND | AIR |
| 65 | Oct 2025 | CENTRAL POINT PHARMACY | Seychelles | Ointment | 39 | NOS | $2.11 | $82.20 | CHENNAI AIR | MAHE ISLAND | AIR |
10
PART VI — DRILL-DOWN · ASIA
Region: Asia
7 countries · 19 shipments · $91K · 10 Indian suppliers · 7 buyers
SHIPMENTS
19
USD
$91K
COUNTRIES
7
SUPPLIERS
10
BUYERS
7
HHI
1,475
competitive
Top 7 destination countries in Asia
1
United Arab Emirates (31.3%)
$29K
2
Turkey (24.2%)
$22K
3
Afghanistan (18.7%)
$17K
4
Sri Lanka (18.5%)
$17K
5
Tajikistan (7.0%)
$6K
6
Turkmenistan (0.4%)
$387.92
7
Maldives (0.0%)
$5.38
Top 10 Indian suppliers into Asia
1
STAR EXPORTS
$20K
2
PROCTER & GAMBLE HYGIENE AND HEALTH CARE LTD
$17K
3
R P L (INDIA) PHARMACEUTICALS PVT LTD
$13K
4
MARKSANS PHARMA LTD
$13K
5
LABORATE PHARMACEUTICALS INDIA LTD
$9K
6
LEDERDAY PHARMA
$9K
7
EVOLET HEALTHCARE PVT LTD
$6K
8
NEON LABORATORIES LTD
$4K
9
AKRITI PHARMACEUTICALS PVT LTD
$387.92
10
HEMS ( INDIA )
$5.38
Top 6 Asia importers
1
HAYLEYS CONSUMER PRODUCTS LTD · Sri Lanka
$17K
2
ORGANO COMPANY FOR TRADING PHARMACE · Turkey
$13K
3
TRADE WINDS INTERNATIONAL FZ - LLCC · United Arab Emirates
$9K
4
DUSTI PHARM LLC · Tajikistan
$6K
5
FAQIR ZAMAN LTD · Afghanistan
$4K
6
TURKMENDERMANSENAGAT ASSOCIATION · Turkmenistan
$387.92
Top 4 dosage forms
1
Syrup
$31K
2
Unknown
$24K
3
Tablet
$19K
4
Solution
$17K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 13 | $58K | $4K |
| Nov | 5 | $34K | $7K |
| Dec | 1 | $5.38 | $5.38 |
Shipment register · 19 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — STAR EXPORTS · 1 shipments · $20K | |||||||||||
| 1 | Nov 2025 | UNLISTED BUYER | United Arab Emirates | 1.1K | KGS | $18.34 | $20K | AHMEDABAD ICD | SHARJAH | ICD | |
| SUPPLIER #2 — PROCTER & GAMBLE HYGIENE AND HEALTH CARE LTD · 1 shipments · $17K | |||||||||||
| 2 | Oct 2025 | HAYLEYS CONSUMER PRODUCTS LTD | Sri Lanka | Solution | 102 | NOS | $165.55 | $17K | NHAVA SHEVA SEA (JNPT) | Colombo | SEA |
| SUPPLIER #3 — R P L (INDIA) PHARMACEUTICALS PVT LTD · 8 shipments · $13K | |||||||||||
| 3 | Oct 2025 | UNLISTED BUYER | Afghanistan | Syrup | 16.8K | NOS | $0.131 | $2K | TUGHLAKABAD ICD | Kandahar | ICD |
| 4 | Oct 2025 | UNLISTED BUYER | Afghanistan | Syrup | 16.8K | NOS | $0.131 | $2K | TUGHLAKABAD ICD | Kandahar | ICD |
| 5 | Oct 2025 | UNLISTED BUYER | Afghanistan | Syrup | 16.6K | NOS | $0.131 | $2K | TUGHLAKABAD ICD | Kandahar | ICD |
| 6 | Oct 2025 | UNLISTED BUYER | Afghanistan | Syrup | 162 | NOS | $0.131 | $21.17 | TUGHLAKABAD ICD | Kandahar | ICD |
| 7 | Oct 2025 | UNLISTED BUYER | Afghanistan | Syrup | 16.8K | NOS | $0.131 | $2K | TUGHLAKABAD ICD | Kandahar | ICD |
| 8 | Oct 2025 | UNLISTED BUYER | Afghanistan | Syrup | 16.8K | NOS | $0.131 | $2K | TUGHLAKABAD ICD | Kandahar | ICD |
| 9 | Oct 2025 | UNLISTED BUYER | Afghanistan | Syrup | 16.6K | NOS | $0.131 | $2K | TUGHLAKABAD ICD | Kandahar | ICD |
| 10 | Oct 2025 | UNLISTED BUYER | Afghanistan | Syrup | 162 | NOS | $0.131 | $21.17 | TUGHLAKABAD ICD | Kandahar | ICD |
| SUPPLIER #4 — MARKSANS PHARMA LTD · 2 shipments · $13K | |||||||||||
| 11 | Oct 2025 | ORGANO COMPANY FOR TRADING PHARMACE | Turkey | Tablet | 34.6K | NOS | $0.364 | $13K | NHAVA SHEVA SEA (JNPT) | Mersin | SEA |
| 12 | Nov 2025 | ORGANO COMPANY FOR TRADING PHARMACE | Turkey | 1 | NOS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Mersin | SEA | |
| SUPPLIER #5 — LABORATE PHARMACEUTICALS INDIA LTD · 1 shipments · $9K | |||||||||||
| 13 | Nov 2025 | UNLISTED BUYER | Turkey | Syrup | 47.3K | NOS | $0.201 | $9K | PATLI ICD | Iskenderun | ICD |
| SUPPLIER #6 — LEDERDAY PHARMA · 2 shipments · $9K | |||||||||||
| 14 | Oct 2025 | TRADE WINDS INTERNATIONAL FZ - LLCC | United Arab Emirates | Syrup | 10.6K | PCS | $0.438 | $5K | NHAVA SHEVA SEA (JNPT) | Jebel Ali | SEA |
| 15 | Oct 2025 | TRADE WINDS INTERNATIONAL FZ - LLCC | United Arab Emirates | Syrup | 9.4K | PCS | $0.438 | $4K | NHAVA SHEVA SEA (JNPT) | Jebel Ali | SEA |
| SUPPLIER #7 — EVOLET HEALTHCARE PVT LTD · 1 shipments · $6K | |||||||||||
| 16 | Oct 2025 | DUSTI PHARM LLC | Tajikistan | Tablet | 6.3K | NOS | $1.02 | $6K | NHAVA SHEVA SEA (JNPT) | Dushanbe | SEA |
| SUPPLIER #8 — NEON LABORATORIES LTD · 1 shipments · $4K | |||||||||||
| 17 | Nov 2025 | FAQIR ZAMAN LTD | Afghanistan | 19.6K | NOS | $0.200 | $4K | NHAVA SHEVA SEA (JNPT) | Kandahar | SEA | |
| SUPPLIER #9 — AKRITI PHARMACEUTICALS PVT LTD · 1 shipments · $387.92 | |||||||||||
| 18 | Nov 2025 | TURKMENDERMANSENAGAT ASSOCIATION | Turkmenistan | Tablet | 28 | NOS | $13.85 | $387.92 | MUMBAI AIR (SAHAR) | ASHKHABAD | AIR |
| SUPPLIER #10 — HEMS ( INDIA ) · 1 shipments · $5.38 | |||||||||||
| 19 | Dec 2025 | UNLISTED BUYER | Maldives | Tablet | 90 | NOS | $0.060 | $5.38 | CHENNAI AIR | MALE | AIR |
10
PART VI — DRILL-DOWN · AMERICAS
Region: Americas
5 countries · 125 shipments · $2.81M · 20 Indian suppliers · 27 buyers
SHIPMENTS
125
USD
$2.81M
COUNTRIES
5
SUPPLIERS
20
BUYERS
27
HHI
1,565
moderate
Top 5 destination countries in Americas
1
United States (96.3%)
$2.71M
2
Nicaragua (1.5%)
$43K
3
Peru (0.8%)
$22K
4
Dominican Republic (0.7%)
$19K
5
Guyana (0.7%)
$19K
Top 20 Indian suppliers into Americas
1
MARKSANS PHARMA LTD
$772K
2
GLAND PHARMA LTD
$546K
3
AVET LIFESCIENCES PVT LTD
$413K
4
SOFTGEL HEALTHCARE PVT LTD
$251K
5
ELYSIUM PHARMACEUTICALS LTD
$242K
6
MICRO LABS LTD
$154K
7
TRUECARE BIOMEDIX
$128K
8
ORBION PHARMACEUTICALS PVT LTD
$67K
9
ALDER BIOCHEM PVT LTD
$61K
10
CIRON DRUGS AND PHARMACEUTICALS PVT LTD
$43K
11
GLOBELA PHARMA PVT LTD
$32K
12
OCEAN HEALTHCARE PVT LTD
$23K
13
XL LABORATORIES PVT LTD
$22K
14
LABDHI PHARMACEUTICALS LLP
$18K
15
AMICO FORMULATIONS LLP
$17K
16
KJD PHARMA PVT LTD
$15K
17
TIWARI PHARMA PVT LTD
$7K
18
ANH PHARMACEUTICALS PVT LTD
$2K
19
H V A INTERNATIONAL
$1K
20
VANCE AND HEALTH PHARMACEUTICALS PVT LTD
$121.25
Top 25 Americas importers
1
TIME-CAP LABS INC · United States
$611K
2
EVERSANA LIFE SCIENCE SERVICES LLC · United States
$546K
3
AVET PHARMACEUTICALS INC · United States
$413K
4
STRIVE PHARMACEUTICALS INC · United States
$200K
5
INTL PHARMA PACKAGING & DISTRIBUTI · United States
$175K
6
CARDINAL 3PL · United States
$154K
7
CABINET HEALTH P.B.C · United States
$101K
8
INTERNATIONAL PHARMA PACKAGING & DI · United States
$67K
9
SHIELD PHARMACEUTICALS CORP · United States
$61K
10
TIME-CAP LABSINC 7 MICHAEL AVENUE · United States
$50K
11
PIONEER LIFE SCIENCE LLC · United States
$42K
12
INT L PHARMA PACKAGING & DISTRIBUTI · United States
$29K
13
SAMJAN GROUP INC · United States
$23K
14
INTIPHARMA S.A · Peru
$22K
15
INTL PHARMA PACKAGING&DISTRIBUTION · United States
$15K
16
HHH PHARMACEUTICALS · United States
$14K
17
PRODOSE INC · United States
$13K
18
AKRON PHARMA INC · United States
$8K
19
ZEYTAA LLC · United States
$7K
20
AIRLIE PHARMA · United States
$7K
21
INTL PHARMA PACKAGING & DISTRIBUTO · United States
$6K
22
TO THE ODRER OF AARNEXT DOMINICANA( · Dominican Republic
$2K
23
NEW GPC INCQUEENS ATLANTIC INDUSTRI · Guyana
$1K
24
MEDEK PHARMA S.A · Dominican Republic
$121.25
25
INT L PHARMA PACKAGING&DISTRIBUTION · United States
$80.06
Top 10 dosage forms
1
Tablet
$1.33M
2
Injection
$816K
3
Capsule
$515K
4
Solution
$49K
5
Softgel Capsule
$29K
6
softgel capsules
$17K
7
softgelatin capsule
$15K
8
Chewable Tablet
$14K
9
Unknown
$13K
10
Other
$11K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 40 | $1.06M | $26K |
| Nov | 50 | $1.09M | $22K |
| Dec | 35 | $666K | $19K |
Shipment register · 125 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — MARKSANS PHARMA LTD · 31 shipments · $772K | |||||||||||
| 1 | Oct 2025 | TIME-CAP LABSINC 7 MICHAEL AVENUE | United States | Capsule | 36.8K | NOS | $0.325 | $12K | NHAVA SHEVA SEA (JNPT) | New York | SEA |
| 2 | Oct 2025 | TIME-CAP LABS INC | United States | Capsule | 37.3K | NOS | $0.328 | $12K | NHAVA SHEVA SEA (JNPT) | New York | SEA |
| 3 | Oct 2025 | TIME-CAP LABS INC | United States | Tablet | 44.1K | NOS | $1.75 | $77K | NHAVA SHEVA SEA (JNPT) | New York | SEA |
| 4 | Oct 2025 | TIME-CAP LABSINC 7 MICHAEL AVENUE | United States | Tablet | 29.3K | NOS | $1.30 | $38K | NHAVA SHEVA SEA (JNPT) | Newark | SEA |
| 5 | Oct 2025 | TIME-CAP LABS INC | United States | Tablet | 26.5K | NOS | $0.823 | $22K | NHAVA SHEVA SEA (JNPT) | New York | SEA |
| 6 | Oct 2025 | TIME-CAP LABS INC | United States | Capsule | 16.4K | NOS | $0.455 | $7K | NHAVA SHEVA SEA (JNPT) | New York | SEA |
| 7 | Oct 2025 | TIME-CAP LABS INC | United States | Tablet | 160.0K | NOS | $0.412 | $66K | NHAVA SHEVA SEA (JNPT) | New York | SEA |
| 8 | Oct 2025 | TIME-CAP LABS INC | United States | Tablet | 8.8K | NOS | $1.70 | $15K | NHAVA SHEVA SEA (JNPT) | New York | SEA |
| 9 | Nov 2025 | TIME-CAP LABS INC | United States | Tablet | 35.6K | NOS | $1.72 | $61K | NHAVA SHEVA SEA (JNPT) | Newark | SEA |
| 10 | Nov 2025 | TIME-CAP LABS INC | United States | Capsule | 37.7K | NOS | $0.454 | $17K | NHAVA SHEVA SEA (JNPT) | Newark | SEA |
| 11 | Nov 2025 | TIME-CAP LABS INC | United States | 17.7K | NOS | $0.362 | $6K | NHAVA SHEVA SEA (JNPT) | New York | SEA | |
| 12 | Nov 2025 | TIME-CAP LABS INC | United States | 17.9K | NOS | $0.360 | $6K | NHAVA SHEVA SEA (JNPT) | New York | SEA | |
| 13 | Nov 2025 | TIME-CAP LABS INC | United States | Tablet | 168.5K | NOS | $0.416 | $70K | NHAVA SHEVA SEA (JNPT) | Newark | SEA |
| 14 | Nov 2025 | UNKNOWN BUYER | United States | Tablet | 168.5K | NOS | $0.416 | $70K | NHAVA SHEVA SEA (JNPT) | Newark | SEA |
| 15 | Nov 2025 | TIME-CAP LABS INC | United States | Tablet | 45.6K | NOS | $0.421 | $19K | NHAVA SHEVA SEA (JNPT) | Newark | SEA |
| 16 | Nov 2025 | TIME-CAP LABS INC | United States | Chewable Tablet | 19.1K | NOS | $0.365 | $7K | NHAVA SHEVA SEA (JNPT) | Newark | SEA |
| 17 | Nov 2025 | UNKNOWN BUYER | United States | Tablet | 45.6K | NOS | $0.421 | $19K | NHAVA SHEVA SEA (JNPT) | Newark | SEA |
| 18 | Nov 2025 | UNKNOWN BUYER | United States | Chewable Tablet | 19.1K | NOS | $0.365 | $7K | NHAVA SHEVA SEA (JNPT) | Newark | SEA |
| 19 | Nov 2025 | UNKNOWN BUYER | United States | Capsule | 17.9K | NOS | $0.856 | $15K | NHAVA SHEVA SEA (JNPT) | Newark | SEA |
| 20 | Nov 2025 | TIME-CAP LABS INC | United States | Tablet | 35.8K | NOS | $1.75 | $63K | NHAVA SHEVA SEA (JNPT) | Newark | SEA |
| 21 | Nov 2025 | TIME-CAP LABS INC | United States | Other | 20.0K | NOS | $0.558 | $11K | NHAVA SHEVA SEA (JNPT) | New York | SEA |
| 22 | Nov 2025 | TIME-CAP LABS INC | United States | Capsule | 10.1K | NOS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Newark | SEA |
| 23 | Nov 2025 | TIME-CAP LABS INC | United States | Capsule | 10.1K | NOS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Newark | SEA |
| 24 | Nov 2025 | TIME-CAP LABS INC | United States | Capsule | 9.2K | NOS | $2.90 | $27K | NHAVA SHEVA SEA (JNPT) | Newark | SEA |
| 25 | Nov 2025 | TIME-CAP LABS INC | United States | Capsule | 10.1K | NOS | $0.859 | $9K | NHAVA SHEVA SEA (JNPT) | Newark | SEA |
| 26 | Dec 2025 | TIME-CAP LABS INC | United States | Tablet | 9.2K | NOS | $0.700 | $6K | NHAVA SHEVA SEA (JNPT) | New York | SEA |
| 27 | Dec 2025 | TIME-CAP LABS INC | United States | Tablet | 38.4K | NOS | $0.167 | $6K | NHAVA SHEVA SEA (JNPT) | Newark | SEA |
| 28 | Dec 2025 | TIME-CAP LABS INC | United States | Tablet | 23.3K | NOS | $0.015 | $346.49 | NHAVA SHEVA SEA (JNPT) | Newark | AIR |
| 29 | Dec 2025 | TIME-CAP LABS INC | United States | Tablet | 5.5K | NOS | $1.31 | $7K | NHAVA SHEVA SEA (JNPT) | Newark | SEA |
| 30 | Dec 2025 | TIME-CAP LABS INC | United States | Tablet | 35.3K | NOS | $1.77 | $63K | NHAVA SHEVA SEA (JNPT) | New York | SEA |
| 31 | Dec 2025 | TIME-CAP LABS INC | United States | Tablet | 17.7K | NOS | $1.78 | $32K | NHAVA SHEVA SEA (JNPT) | Newark | SEA |
| SUPPLIER #2 — GLAND PHARMA LTD · 8 shipments · $546K | |||||||||||
| 32 | Oct 2025 | EVERSANA LIFE SCIENCE SERVICES LLC | United States | Injection | 151.2K | NOS | $0.457 | $69K | HYDERABAD ICD | SAVANNAH | ICD |
| 33 | Oct 2025 | EVERSANA LIFE SCIENCE SERVICES LLC | United States | Injection | 167.3K | NOS | $0.457 | $76K | HYDERABAD ICD | SAVANNAH | ICD |
| 34 | Oct 2025 | EVERSANA LIFE SCIENCE SERVICES LLC | United States | Injection | 169.2K | NOS | $0.457 | $77K | HYDERABAD ICD | SAVANNAH | ICD |
| 35 | Oct 2025 | EVERSANA LIFE SCIENCE SERVICES LLC | United States | Injection | 169.0K | NOS | $0.457 | $77K | HYDERABAD AIR | CHICAGO O'HARE INT'L | AIR |
| 36 | Oct 2025 | EVERSANA LIFE SCIENCE SERVICES LLC | United States | Injection | 17.8K | NOS | $0.461 | $8K | HYDERABAD ICD | SAVANNAH | ICD |
| 37 | Oct 2025 | EVERSANA LIFE SCIENCE SERVICES LLC | United States | Injection | 170.5K | NOS | $0.456 | $78K | HYDERABAD ICD | Savannah | ICD |
| 38 | Dec 2025 | EVERSANA LIFE SCIENCE SERVICES LLC | United States | Injection | 169.7K | NOS | $0.469 | $80K | HYDERABAD ICD | SAVANNAH | ICD |
| 39 | Dec 2025 | EVERSANA LIFE SCIENCE SERVICES LLC | United States | Injection | 170.8K | NOS | $0.469 | $80K | HYDERABAD ICD | SAVANNAH | ICD |
| SUPPLIER #3 — AVET LIFESCIENCES PVT LTD · 8 shipments · $413K | |||||||||||
| 40 | Oct 2025 | AVET PHARMACEUTICALS INC | United States | Injection | 4.2K | VLS | $8.79 | $37K | BANGALORE AIR | CHICAGO O'HARE INT'L | AIR |
| 41 | Oct 2025 | AVET PHARMACEUTICALS INC | United States | Injection | 4.1K | VLS | $8.79 | $36K | BANGALORE AIR | CHICAGO O'HARE INT'L | AIR |
| 42 | Oct 2025 | AVET PHARMACEUTICALS INC | United States | Injection | 4.1K | VLS | $8.79 | $36K | BANGALORE AIR | CHICAGO O'HARE INT'L | AIR |
| 43 | Nov 2025 | AVET PHARMACEUTICALS INC | United States | Tablet | 5.4K | VLS | $8.68 | $47K | BANGALORE AIR | CHICAGO O'HARE INT'L | AIR |
| 44 | Nov 2025 | AVET PHARMACEUTICALS INC | United States | Tablet | 7.2K | VLS | $8.68 | $62K | BANGALORE AIR | CHICAGO O'HARE INT'L | AIR |
| 45 | Nov 2025 | AVET PHARMACEUTICALS INC | United States | Tablet | 7.2K | VLS | $8.68 | $63K | BANGALORE AIR | CHICAGO O'HARE INT'L | AIR |
| 46 | Nov 2025 | AVET PHARMACEUTICALS INC | United States | Tablet | 7.4K | VLS | $8.68 | $65K | BANGALORE AIR | CHICAGO O'HARE INT'L | AIR |
| 47 | Nov 2025 | AVET PHARMACEUTICALS INC | United States | Tablet | 7.8K | VLS | $8.68 | $67K | BANGALORE AIR | CHICAGO O'HARE INT'L | AIR |
| SUPPLIER #4 — SOFTGEL HEALTHCARE PVT LTD · 26 shipments · $251K | |||||||||||
| 48 | Oct 2025 | INTL PHARMA PACKAGING&DISTRIBUTION | United States | softgelatin capsule | 9.5K | NOS | $0.426 | $4K | BANGALORE AIR | ATLANTA, HARTSFIELD | AIR |
| 49 | Oct 2025 | INTL PHARMA PACKAGING&DISTRIBUTION | United States | softgelatin capsule | 4.8K | NOS | $0.426 | $2K | BANGALORE AIR | ATLANTA, HARTSFIELD | AIR |
| 50 | Oct 2025 | INTL PHARMA PACKAGING&DISTRIBUTION | United States | softgelatin capsule | 10.3K | NOS | $0.827 | $9K | BANGALORE AIR | ATLANTA, HARTSFIELD | AIR |
| 51 | Oct 2025 | INTL PHARMA PACKAGING & DISTRIBUTI | United States | softgel capsules | 38.9K | NOS | $0.426 | $17K | NHAVA SHEVA SEA (JNPT) | Savannah | SEA |
| 52 | Oct 2025 | INTL PHARMA PACKAGING & DISTRIBUTI | United States | Capsule | 10.0K | NOS | $0.812 | $8K | NHAVA SHEVA SEA (JNPT) | Savannah | SEA |
| 53 | Oct 2025 | INTL PHARMA PACKAGING & DISTRIBUTI | United States | Capsule | 9.8K | NOS | $0.827 | $8K | NHAVA SHEVA SEA (JNPT) | Savannah | SEA |
| 54 | Oct 2025 | INTL PHARMA PACKAGING & DISTRIBUTO | United States | Capsule | 7.7K | NOS | $0.817 | $6K | NHAVA SHEVA SEA (JNPT) | Savannah | SEA |
| 55 | Nov 2025 | INTL PHARMA PACKAGING & DISTRIBUTI | United States | Capsule | 9.2K | NOS | $0.485 | $4K | NHAVA SHEVA SEA (JNPT) | Savannah | SEA |
| 56 | Nov 2025 | INTL PHARMA PACKAGING & DISTRIBUTI | United States | Capsule | 11.7K | NOS | $1.98 | $23K | NHAVA SHEVA SEA (JNPT) | Savannah | SEA |
| 57 | Nov 2025 | INTL PHARMA PACKAGING & DISTRIBUTI | United States | Capsule | 29.8K | NOS | $0.846 | $25K | NHAVA SHEVA SEA (JNPT) | Savannah | SEA |
| 58 | Nov 2025 | INTL PHARMA PACKAGING & DISTRIBUTI | United States | Capsule | 9.2K | NOS | $0.485 | $4K | NHAVA SHEVA SEA (JNPT) | Savannah | SEA |
| 59 | Nov 2025 | INTL PHARMA PACKAGING & DISTRIBUTI | United States | Capsule | 16.0K | NOS | $0.824 | $13K | NHAVA SHEVA SEA (JNPT) | Savannah | SEA |
| 60 | Nov 2025 | INTL PHARMA PACKAGING & DISTRIBUTI | United States | Capsule | 19.2K | NOS | $0.424 | $8K | NHAVA SHEVA SEA (JNPT) | Savannah | SEA |
| 61 | Nov 2025 | INTL PHARMA PACKAGING & DISTRIBUTI | United States | Capsule | 9.4K | NOS | $0.424 | $4K | NHAVA SHEVA SEA (JNPT) | Savannah | SEA |
| 62 | Nov 2025 | UNKNOWN BUYER | United States | Capsule | 16.0K | NOS | $0.824 | $13K | NHAVA SHEVA SEA (JNPT) | Savannah | SEA |
| 63 | Nov 2025 | UNKNOWN BUYER | United States | Capsule | 19.2K | NOS | $0.424 | $8K | NHAVA SHEVA SEA (JNPT) | Savannah | SEA |
| 64 | Nov 2025 | UNKNOWN BUYER | United States | Capsule | 9.4K | NOS | $0.424 | $4K | NHAVA SHEVA SEA (JNPT) | Savannah | SEA |
| 65 | Nov 2025 | INT L PHARMA PACKAGING & DISTRIBUTI | United States | Softgel Capsule | 19.7K | PCS | $0.824 | $16K | CHENNAI SEA | Savannah | SEA |
| 66 | Nov 2025 | INT L PHARMA PACKAGING & DISTRIBUTI | United States | Softgel Capsule | 6.5K | PCS | $0.809 | $5K | CHENNAI SEA | Savannah | SEA |
| 67 | Nov 2025 | INT L PHARMA PACKAGING & DISTRIBUTI | United States | Softgel Capsule | 18.0K | PCS | $0.424 | $8K | CHENNAI SEA | Savannah | SEA |
| 68 | Dec 2025 | INT L PHARMA PACKAGING&DISTRIBUTION | United States | Capsule | 4.8K | PCS | $0.017 | $80.06 | CHENNAI SEA | Savannah | SEA |
| 69 | Dec 2025 | INTL PHARMA PACKAGING & DISTRIBUTI | United States | Capsule | 5.9K | NOS | $2.04 | $12K | NHAVA SHEVA SEA (JNPT) | Savannah | SEA |
| 70 | Dec 2025 | INTL PHARMA PACKAGING & DISTRIBUTI | United States | Capsule | 18.2K | NOS | $0.433 | $8K | NHAVA SHEVA SEA (JNPT) | Savannah | SEA |
| 71 | Dec 2025 | INTL PHARMA PACKAGING & DISTRIBUTI | United States | Capsule | 5.4K | NOS | $0.500 | $3K | NHAVA SHEVA SEA (JNPT) | Savannah | SEA |
| 72 | Dec 2025 | INTL PHARMA PACKAGING & DISTRIBUTI | United States | Capsule | 37.5K | NOS | $0.841 | $32K | NHAVA SHEVA SEA (JNPT) | Savannah | SEA |
| 73 | Dec 2025 | INTL PHARMA PACKAGING & DISTRIBUTI | United States | Capsule | 11.4K | NOS | $0.479 | $5K | NHAVA SHEVA SEA (JNPT) | Savannah | SEA |
| SUPPLIER #5 — ELYSIUM PHARMACEUTICALS LTD · 11 shipments · $242K | |||||||||||
| 74 | Oct 2025 | PIONEER LIFE SCIENCE LLC | United States | Capsule | 52 | NOS | $329.22 | $17K | MUNDRA SEA | New York | SEA |
| 75 | Nov 2025 | HHH PHARMACEUTICALS | United States | Tablet | 40 | NOS | $233.14 | $9K | MUNDRA SEA | New York | SEA |
| 76 | Nov 2025 | HHH PHARMACEUTICALS | United States | Tablet | 20 | NOS | $232.67 | $5K | MUNDRA SEA | New York | SEA |
| 77 | Nov 2025 | CABINET HEALTH P.B.C | United States | Tablet | 90 | NOS | $248.06 | $22K | MUNDRA SEA | New York | SEA |
| 78 | Nov 2025 | CABINET HEALTH P.B.C | United States | Tablet | 100 | NOS | $263.51 | $26K | MUNDRA SEA | New York | SEA |
| 79 | Nov 2025 | PIONEER LIFE SCIENCE LLC | United States | Tablet | 100 | NOS | $243.85 | $24K | MUNDRA SEA | New York | SEA |
| 80 | Nov 2025 | PRODOSE INC | United States | Capsule | 25 | NOS | $327.07 | $8K | MUNDRA SEA | New York | SEA |
| 81 | Nov 2025 | PRODOSE INC | United States | Tablet | 20 | NOS | $241.57 | $5K | MUNDRA SEA | New York | SEA |
| 82 | Nov 2025 | STRIVE PHARMACEUTICALS INC | United States | Capsule | 59 | NOS | $663.11 | $39K | MUNDRA SEA | New York | SEA |
| 83 | Dec 2025 | STRIVE PHARMACEUTICALS INC | United States | Capsule | 103 | NOS | $322.34 | $33K | MUNDRA SEA | New York | SEA |
| 84 | Dec 2025 | CABINET HEALTH P.B.C | United States | Tablet | 200 | NOS | $262.25 | $52K | MUNDRA SEA | New York | SEA |
| SUPPLIER #6 — MICRO LABS LTD · 2 shipments · $154K | |||||||||||
| 85 | Oct 2025 | CARDINAL 3PL | United States | Injection | 6.2K | PCS | $12.29 | $76K | ENNORE SEA | Savannah | SEA |
| 86 | Oct 2025 | CARDINAL 3PL | United States | Injection | 6.3K | PCS | $12.28 | $77K | ENNORE SEA | Savannah | SEA |
| SUPPLIER #7 — TRUECARE BIOMEDIX · 5 shipments · $128K | |||||||||||
| 87 | Oct 2025 | STRIVE PHARMACEUTICALS INC | United States | Tablet | 7.5M | NOS | $0.0020 | $15K | MUNDRA SEA | New York | SEA |
| 88 | Oct 2025 | STRIVE PHARMACEUTICALS INC | United States | Capsule | 2.5M | NOS | $0.0034 | $9K | MUNDRA SEA | New York | SEA |
| 89 | Oct 2025 | STRIVE PHARMACEUTICALS INC | United States | Tablet | 7.5M | NOS | $0.0020 | $15K | MUNDRA SEA | New York | SEA |
| 90 | Dec 2025 | STRIVE PHARMACEUTICALS INC | United States | Capsule | 5.5M | NOS | $0.0035 | $19K | MUNDRA SEA | New York | SEA |
| 91 | Dec 2025 | STRIVE PHARMACEUTICALS INC | United States | Tablet | 35.0M | NOS | $0.0020 | $71K | MUNDRA SEA | New York | SEA |
| SUPPLIER #8 — ORBION PHARMACEUTICALS PVT LTD · 6 shipments · $67K | |||||||||||
| 92 | Nov 2025 | INTERNATIONAL PHARMA PACKAGING & DI | United States | Tablet | 30.9K | NOS | $0.386 | $12K | NHAVA SHEVA SEA (JNPT) | Savannah | SEA |
| 93 | Nov 2025 | INTERNATIONAL PHARMA PACKAGING & DI | United States | Tablet | 3.6K | NOS | $2.97 | $11K | NHAVA SHEVA SEA (JNPT) | Savannah | SEA |
| 94 | Nov 2025 | INTERNATIONAL PHARMA PACKAGING & DI | United States | Tablet | 3.5K | NOS | $2.97 | $11K | NHAVA SHEVA SEA (JNPT) | Savannah | SEA |
| 95 | Nov 2025 | INTERNATIONAL PHARMA PACKAGING & DI | United States | Tablet | 3.6K | NOS | $2.97 | $11K | NHAVA SHEVA SEA (JNPT) | Savannah | SEA |
| 96 | Nov 2025 | INTERNATIONAL PHARMA PACKAGING & DI | United States | Tablet | 14.4K | NOS | $0.386 | $6K | BANGALORE AIR | ATLANTA, HARTSFIELD | AIR |
| 97 | Dec 2025 | INTERNATIONAL PHARMA PACKAGING & DI | United States | Tablet | 45.0K | NOS | $0.398 | $18K | NHAVA SHEVA SEA (JNPT) | Savannah | SEA |
| SUPPLIER #9 — ALDER BIOCHEM PVT LTD · 6 shipments · $61K | |||||||||||
| 98 | Oct 2025 | SHIELD PHARMACEUTICALS CORP | United States | Capsule | 737 | NOS | $10.97 | $8K | DADRI ICD | NEW YORK | ICD |
| 99 | Oct 2025 | SHIELD PHARMACEUTICALS CORP | United States | Capsule | 1.9K | NOS | $10.97 | $21K | DADRI ICD | NEW YORK | ICD |
| 100 | Oct 2025 | SHIELD PHARMACEUTICALS CORP | United States | Capsule | 774 | NOS | $10.11 | $8K | DADRI ICD | NEW YORK | ICD |
| 101 | Dec 2025 | SHIELD PHARMACEUTICALS CORP | United States | Capsule | 1.3K | NOS | $11.27 | $15K | DADRI ICD | NEW YORK | ICD |
| 102 | Dec 2025 | SHIELD PHARMACEUTICALS CORP | United States | Capsule | 539 | NOS | $10.39 | $6K | DADRI ICD | NEW YORK | ICD |
| 103 | Dec 2025 | SHIELD PHARMACEUTICALS CORP | United States | Capsule | 29.5K | NOS | $0.130 | $4K | DADRI ICD | NEW YORK | ICD |
| SUPPLIER #10 — CIRON DRUGS AND PHARMACEUTICALS PVT LTD · 1 shipments · $43K | |||||||||||
| 104 | Dec 2025 | UNLISTED BUYER | Nicaragua | Solution | 120.0K | NOS | $0.359 | $43K | NHAVA SHEVA SEA (JNPT) | Corinto | SEA |
| SUPPLIER #11 — GLOBELA PHARMA PVT LTD · 1 shipments · $32K | |||||||||||
| 105 | Nov 2025 | UNLISTED BUYER | United States | Tablet | 12.0M | NOS | $0.0026 | $32K | HAZIRA ICD | NEW YORK | SEA |
| SUPPLIER #12 — OCEAN HEALTHCARE PVT LTD · 1 shipments · $23K | |||||||||||
| 106 | Nov 2025 | SAMJAN GROUP INC | United States | Tablet | 9.8M | NOS | $0.0023 | $23K | CHENNAI SEA | New York | SEA |
| SUPPLIER #13 — XL LABORATORIES PVT LTD · 1 shipments · $22K | |||||||||||
| 107 | Dec 2025 | INTIPHARMA S.A | Peru | Capsule | 9.4K | NOS | $2.37 | $22K | DELHI AIR | LIMA - | AIR |
| SUPPLIER #14 — LABDHI PHARMACEUTICALS LLP · 4 shipments · $18K | |||||||||||
| 108 | Dec 2025 | UNLISTED BUYER | Guyana | Tablet | 125 | NOS | $30.60 | $4K | MUMBAI AIR (SAHAR) | GEORGETOWN | AIR |
| 109 | Dec 2025 | UNLISTED BUYER | Guyana | Injection | 400 | NOS | $4.08 | $2K | MUMBAI AIR (SAHAR) | GEORGETOWN | AIR |
| 110 | Dec 2025 | UNLISTED BUYER | Guyana | Tablet | 205 | NOS | $30.60 | $6K | NHAVA SHEVA SEA (JNPT) | Georgetown | SEA |
| 111 | Dec 2025 | UNLISTED BUYER | Guyana | Injection | 1.6K | NOS | $4.08 | $6K | NHAVA SHEVA SEA (JNPT) | Georgetown | SEA |
| SUPPLIER #15 — AMICO FORMULATIONS LLP · 1 shipments · $17K | |||||||||||
| 112 | Dec 2025 | UNLISTED BUYER | Dominican Republic | Tablet | 970 | THD | $17.59 | $17K | NHAVA SHEVA SEA (JNPT) | CAUCEDO DOMINIC REP. | SEA |
| SUPPLIER #16 — KJD PHARMA PVT LTD · 8 shipments · $15K | |||||||||||
| 113 | Oct 2025 | AIRLIE PHARMA | United States | Capsule | 3.6K | NOS | $0.358 | $1K | HYDERABAD ICD | SAVANNAH | ICD |
| 114 | Oct 2025 | AKRON PHARMA INC | United States | Capsule | 576 | UNT | $0.396 | $228.30 | HYDERABAD AIR | NEW YORK - JOHN F. K | AIR |
| 115 | Oct 2025 | AKRON PHARMA INC | United States | Capsule | 8.7K | UNT | $0.396 | $3K | HYDERABAD AIR | NEW YORK - JOHN F. K | AIR |
| 116 | Oct 2025 | AKRON PHARMA INC | United States | Capsule | 7.9K | UNT | $0.396 | $3K | HYDERABAD AIR | NEW YORK - JOHN F. K | AIR |
| 117 | Oct 2025 | AKRON PHARMA INC | United States | Capsule | 876 | UNT | $1.14 | $998.22 | HYDERABAD AIR | NEW YORK - JOHN F. K | AIR |
| 118 | Dec 2025 | AIRLIE PHARMA | United States | Solution | 3.9K | NOS | $0.406 | $2K | HYDERABAD ICD | SAVANNAH | ICD |
| 119 | Dec 2025 | AIRLIE PHARMA | United States | Solution | 3.6K | NOS | $0.813 | $3K | HYDERABAD ICD | SAVANNAH | ICD |
| 120 | Dec 2025 | AIRLIE PHARMA | United States | Solution | 852 | NOS | $1.63 | $1K | HYDERABAD ICD | SAVANNAH | ICD |
| SUPPLIER #17 — TIWARI PHARMA PVT LTD · 1 shipments · $7K | |||||||||||
| 121 | Dec 2025 | ZEYTAA LLC | United States | Capsule | 1.0K | NOS | $7.25 | $7K | DADRI ICD | NEW YORK | ICD |
| SUPPLIER #18 — ANH PHARMACEUTICALS PVT LTD · 1 shipments · $2K | |||||||||||
| 122 | Oct 2025 | TO THE ODRER OF AARNEXT DOMINICANA( | Dominican Republic | Syrup | 10.0K | NOS | $0.213 | $2K | NHAVA SHEVA SEA (JNPT) | CAUCEDO DOMINIC REP. | SEA |
| SUPPLIER #19 — H V A INTERNATIONAL · 1 shipments · $1K | |||||||||||
| 123 | Oct 2025 | NEW GPC INCQUEENS ATLANTIC INDUSTRI | Guyana | Tablet | 576 | NOS | $1.83 | $1K | NHAVA SHEVA SEA (JNPT) | Georgetown | SEA |
| SUPPLIER #20 — VANCE AND HEALTH PHARMACEUTICALS PVT LTD · 2 shipments · $121.25 | |||||||||||
| 124 | Dec 2025 | MEDEK PHARMA S.A | Dominican Republic | Syrup | 50.2K | NOS | $0.0012 | $60.75 | MUNDRA SEA | CAUCEDO DOMINIC REP. | SEA |
| 125 | Dec 2025 | MEDEK PHARMA S.A | Dominican Republic | Syrup | 50.0K | NOS | $0.0012 | $60.50 | MUNDRA SEA | CAUCEDO DOMINIC REP. | SEA |
10
PART VI — DRILL-DOWN · OCEANIA
Region: Oceania
1 countries · 1 shipments · $5K · 1 Indian suppliers · 1 buyers
SHIPMENTS
1
USD
$5K
COUNTRIES
1
SUPPLIERS
1
BUYERS
1
HHI
10,000
concentrated
Top 1 destination countries in Oceania
1
Papua New Guinea (100.0%)
$5K
Top 1 Indian suppliers into Oceania
1
ARIHANT EXPORTERS
$5K
Top 1 Oceania importers
1
SESAGO HEALTH CARE LTD · Papua New Guinea
$5K
Top 1 dosage forms
1
Syrup
$5K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 1 | $5K | $5K |
| Nov | 0 | $0.0000 | — |
| Dec | 0 | $0.0000 | — |
Shipment register · 1 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — ARIHANT EXPORTERS · 1 shipments · $5K | |||||||||||
| 1 | Oct 2025 | SESAGO HEALTH CARE LTD | Papua New Guinea | Syrup | 15.0K | PCS | $0.327 | $5K | NHAVA SHEVA SEA (JNPT) | Port Moresby | SEA |
10
PART VI — EVIDENCE REGISTER
Indian Supplier Directory
All 44 Indian diphenhydramine exporters — complete list ranked by USD
KEY TAKEAWAY
This directory lists every Indian company that shipped diphenhydramine in 2025-Q4.
S FOR SUPPLIERS
Find yourself and your competitors. Compare shipment count, USD, and destination regions.
B FOR BUYERS
Search for potential Indian suppliers. Filter by dosage form and destination region.
| # | Supplier | City | Ships | USD | Dosage forms | Primary regions |
|---|---|---|---|---|---|---|
| 1 | MARKSANS PHARMA LTD | MUMBAI | 33 | $785K | Capsule, Tablet, Chewable Tablet | Americas, Asia |
| 2 | INTACT DRUGS AND PHARMACEUTICLAS PVT LTD | PANIPAT | 9 | $564K | Syrup | Africa |
| 3 | GLAND PHARMA LTD | SANGAREDDY | 8 | $546K | Injection | Americas |
| 4 | AVET LIFESCIENCES PVT LTD | WAKAD | 8 | $413K | Injection, Tablet | Americas |
| 5 | CURE & CARE DRUGS PVT LTD | ROORKEE | 6 | $364K | Tablet | Africa |
| 6 | SOFTGEL HEALTHCARE PVT LTD | KANCHEEPURAM DIST | 26 | $251K | softgelatin capsule, softgel capsules, Capsule | Americas |
| 7 | ELYSIUM PHARMACEUTICALS LTD | DIST. VADODARA | 11 | $242K | Capsule, Tablet | Americas |
| 8 | SAKAR HEALTHCARE LTD | AHMEDABAD | 12 | $185K | Syrup | Africa |
| 9 | MICRO LABS LTD | BANGALORE | 2 | $154K | Injection | Americas |
| 10 | TRUECARE BIOMEDIX | BALASINOR | 5 | $128K | Tablet, Capsule | Americas |
| 11 | OM LIFE SCIENCE | HARIDWAR | 20 | $123K | Syrup | Africa |
| 12 | ALPHARD PHARMA | ANKLESHWAR | 1 | $68K | Other | Africa |
| 13 | KOPRAN LTD | WORLI | 1 | $68K | Capsule | Africa |
| 14 | ORBION PHARMACEUTICALS PVT LTD | SRIPERUMBUDUR | 6 | $67K | Tablet | Americas |
| 15 | ALDER BIOCHEM PVT LTD | DEHRADUN | 6 | $61K | Capsule | Americas |
| 16 | CIRON DRUGS AND PHARMACEUTICALS PVT LTD | PALGHAR | 1 | $43K | Solution | Americas |
| 17 | CADILA PHARMACEUTICALS LTD | AHMEDABAD | 1 | $36K | Tablet | Africa |
| 18 | GLOBELA PHARMA PVT LTD | SURAT | 1 | $32K | Tablet | Americas |
| 19 | SANGHARSH LIFECARE PVT LTD | MAKARBA AHMEDABAD GUJARAT INDIA | 2 | $29K | Tablet | Africa |
| 20 | OCEAN HEALTHCARE PVT LTD | THIRUKALUKUNDRAM | 1 | $23K | Tablet | Americas |
| 21 | XL LABORATORIES PVT LTD | NEEMRANA | 1 | $22K | Capsule | Americas |
| 22 | MEDICAMEN BIOTECH LTD | NEW DELHI | 3 | $21K | Solution | Africa |
| 23 | STAR EXPORTS | AHMEDABAD | 1 | $20K | Asia | |
| 24 | LABDHI PHARMACEUTICALS LLP | MUMBAI | 4 | $18K | Tablet, Injection | Americas |
| 25 | AMICO FORMULATIONS LLP | COLABA | 1 | $17K | Tablet | Americas |
| 26 | PROCTER & GAMBLE HYGIENE AND HEALTH CARE LTD | MUMBAI | 1 | $17K | Solution | Asia |
| 27 | KJD PHARMA PVT LTD | BIDAR | 8 | $15K | Capsule, Solution | Americas |
| 28 | R P L (INDIA) PHARMACEUTICALS PVT LTD | NEW DELHI | 8 | $13K | Syrup | Asia |
| 29 | LABORATE PHARMACEUTICALS INDIA LTD | HIMANCHAL PRADESH | 1 | $9K | Syrup | Asia |
| 30 | LEDERDAY PHARMA | NEW DELHI | 2 | $9K | Syrup | Asia |
| 31 | TIWARI PHARMA PVT LTD | HARIDWAR | 1 | $7K | Capsule | Americas |
| 32 | EVOLET HEALTHCARE PVT LTD | NEW DELHI | 1 | $6K | Tablet | Asia |
| 33 | ARIHANT EXPORTERS | SURENDRANAGAR/GUJARAT | 1 | $5K | Syrup | Oceania |
| 34 | SYNCOM FORMULATIONS (INDIA) LTD | PITHAMPUR | 4 | $4K | Solution, Syrup | Africa |
| 35 | NEON LABORATORIES LTD | ANDHERI EAST | 1 | $4K | Asia | |
| 36 | SHALINA LABORATORIES PVT LTD | MUMBAI | 1 | $3K | Syrup | Africa |
| 37 | ANH PHARMACEUTICALS PVT LTD | VADODARA | 1 | $2K | Syrup | Americas |
| 38 | H V A INTERNATIONAL | CENTER | 1 | $1K | Tablet | Americas |
| 39 | GLOBAL PHARMA HEALTHCARE PVT LTD | KANCHIPURAM THIRUPORUR | 1 | $964.85 | Syrup | Africa |
| 40 | CUIDADO MEDICO PVT LTD | AHMEDABAD | 2 | $857.63 | Cream | Africa |
| 41 | AKRITI PHARMACEUTICALS PVT LTD | THANE WEST | 1 | $387.92 | Tablet | Asia |
| 42 | VANCE AND HEALTH PHARMACEUTICALS PVT LTD | ROORKEE | 2 | $121.25 | Syrup | Americas |
| 43 | NALIINI.R.EXPORT PVT LTD | CHENNAI | 2 | $84.28 | Injection, Ointment | Africa |
| 44 | HEMS ( INDIA ) | CHENNAI | 1 | $5.38 | Tablet | Asia |
10
PART VI — EVIDENCE REGISTER
Global Buyer Directory
All 43 global diphenhydramine importers — complete list ranked by USD
KEY TAKEAWAY
This directory lists every company that imported Indian diphenhydramine in 2025-Q4.
S FOR SUPPLIERS
Search for potential customers by country and dosage form.
B FOR BUYERS
Find your company and see which Indian supplier serves you.
| # | Buyer | Country | Ships | USD | Primary supplier | Dosage forms |
|---|---|---|---|---|---|---|
| 1 | TIME-CAP LABS INC | United States | 25 | $611K | MARKSANS PHARMA LTD | Capsule, Tablet, Chewable Tablet |
| 2 | EVERSANA LIFE SCIENCE SERVICES LLC | United States | 8 | $546K | GLAND PHARMA LTD | Injection |
| 3 | AVET PHARMACEUTICALS INC | United States | 8 | $413K | AVET LIFESCIENCES PV… | Injection, Tablet |
| 4 | MOUSSA SA | Benin | 6 | $364K | CURE & CARE DRUGS PV… | Tablet |
| 5 | STRIVE PHARMACEUTICALS INC | United States | 7 | $200K | TRUECARE BIOMEDIX | Tablet, Capsule |
| 6 | AMIPHARMA LABORATORIES LTD | Sudan | 12 | $185K | SAKAR HEALTHCARE LTD | Syrup |
| 7 | INTL PHARMA PACKAGING & DISTRIBUTI | United States | 15 | $175K | SOFTGEL HEALTHCARE P… | softgel capsules, Capsule |
| 8 | CARDINAL 3PL | United States | 2 | $154K | MICRO LABS LTD | Injection |
| 9 | R PHARMA | Republic of the Congo | 20 | $123K | OM LIFE SCIENCE | Syrup |
| 10 | CABINET HEALTH P.B.C | United States | 3 | $101K | ELYSIUM PHARMACEUTIC… | Tablet |
| 11 | SAVE INTERNATIONAL CONCEPT SARL | Chad | 1 | $68K | ALPHARD PHARMA | Other |
| 12 | INTERNATIONAL PHARMA PACKAGING & DI | United States | 6 | $67K | ORBION PHARMACEUTICA… | Tablet |
| 13 | SHIELD PHARMACEUTICALS CORP | United States | 6 | $61K | ALDER BIOCHEM PVT LTD | Capsule |
| 14 | TIME-CAP LABSINC 7 MICHAEL AVENUE | United States | 2 | $50K | MARKSANS PHARMA LTD | Capsule, Tablet |
| 15 | PIONEER LIFE SCIENCE LLC | United States | 2 | $42K | ELYSIUM PHARMACEUTIC… | Capsule, Tablet |
| 16 | CADILA PHARMACEUTICALS (E.A.) LTD | Kenya | 1 | $36K | CADILA PHARMACEUTICA… | Tablet |
| 17 | INT L PHARMA PACKAGING & DISTRIBUTI | United States | 3 | $29K | SOFTGEL HEALTHCARE P… | Softgel Capsule |
| 18 | REALS PHARMACEUTICALS LTD | Nigeria | 2 | $29K | SANGHARSH LIFECARE P… | Tablet |
| 19 | SAMJAN GROUP INC | United States | 1 | $23K | OCEAN HEALTHCARE PVT… | Tablet |
| 20 | INTIPHARMA S.A | Peru | 1 | $22K | XL LABORATORIES PVT … | Capsule |
| 21 | HAYLEYS CONSUMER PRODUCTS LTD | Sri Lanka | 1 | $17K | PROCTER & GAMBLE HYG… | Solution |
| 22 | INTL PHARMA PACKAGING&DISTRIBUTION | United States | 3 | $15K | SOFTGEL HEALTHCARE P… | softgelatin capsule |
| 23 | HHH PHARMACEUTICALS | United States | 2 | $14K | ELYSIUM PHARMACEUTIC… | Tablet |
| 24 | PRODOSE INC | United States | 2 | $13K | ELYSIUM PHARMACEUTIC… | Capsule, Tablet |
| 25 | ORGANO COMPANY FOR TRADING PHARMACE | Turkey | 2 | $13K | MARKSANS PHARMA LTD | Tablet |
| 26 | TRADE WINDS INTERNATIONAL FZ - LLCC | United Arab Emirates | 2 | $9K | LEDERDAY PHARMA | Syrup |
| 27 | AKRON PHARMA INC | United States | 4 | $8K | KJD PHARMA PVT LTD | Capsule |
| 28 | ZEYTAA LLC | United States | 1 | $7K | TIWARI PHARMA PVT LTD | Capsule |
| 29 | AIRLIE PHARMA | United States | 4 | $7K | KJD PHARMA PVT LTD | Capsule, Solution |
| 30 | DUSTI PHARM LLC | Tajikistan | 1 | $6K | EVOLET HEALTHCARE PV… | Tablet |
| 31 | INTL PHARMA PACKAGING & DISTRIBUTO | United States | 1 | $6K | SOFTGEL HEALTHCARE P… | Capsule |
| 32 | SESAGO HEALTH CARE LTD | Papua New Guinea | 1 | $5K | ARIHANT EXPORTERS | Syrup |
| 33 | FAQIR ZAMAN LTD | Afghanistan | 1 | $4K | NEON LABORATORIES LTD | |
| 34 | SHALINA HEALTHCARE SARL | DR Congo | 1 | $3K | SHALINA LABORATORIES… | Syrup |
| 35 | TO THE ODRER OF AARNEXT DOMINICANA( | Dominican Republic | 1 | $2K | ANH PHARMACEUTICALS … | Syrup |
| 36 | DASYN PHARMACEUTICAL (SL) LTD | Sierra Leone | 1 | $2K | SYNCOM FORMULATIONS … | Solution |
| 37 | DEVESH PHARMACEUTICALS INC | Liberia | 1 | $1K | SYNCOM FORMULATIONS … | Solution |
| 38 | NEW GPC INCQUEENS ATLANTIC INDUSTRI | Guyana | 1 | $1K | H V A INTERNATIONAL | Tablet |
| 39 | CUREPHARM LTD | Mauritius | 2 | $857.63 | CUIDADO MEDICO PVT LTD | Cream |
| 40 | TURKMENDERMANSENAGAT ASSOCIATION | Turkmenistan | 1 | $387.92 | AKRITI PHARMACEUTICA… | Tablet |
| 41 | MEDEK PHARMA S.A | Dominican Republic | 2 | $121.25 | VANCE AND HEALTH PHA… | Syrup |
| 42 | CENTRAL POINT PHARMACY | Seychelles | 2 | $84.28 | NALIINI.R.EXPORT PVT… | Injection, Ointment |
| 43 | INT L PHARMA PACKAGING&DISTRIBUTION | United States | 1 | $80.06 | SOFTGEL HEALTHCARE P… | Capsule |
This report covers 210 2025-Q4 Diphenhydramine shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/diphenhydramine
Talk to our trade analyst
Need a custom diphenhydramine report or a deeper dive into any market? Our team is ready.
WhatsApp: +91 95950 78788 · transdatanexus.com
PHARMA TRADE INTELLIGENCE
Thank you for reading
This report is part of the TransData Nexus Pharma Trade Intelligence series, covering 366 pharmaceutical products exported from India.
Every figure is grounded in real commercial trade records — official customs filings and licensed databases. No surveys, no estimates, no fake data.
Need a custom report?
We can generate intelligence for any pharmaceutical product, any time period, any combination of source and destination countries.
Want deeper analysis?
Our team provides competitive intelligence, market entry strategy, and supply chain due diligence for pharma importers and exporters.
Scan for product page
WhatsApp: +91 95950 78788
Email: info@transdatanexus.com
Web: https://transdatanexus.com/pharmaceutical/diphenhydramine
© 2026 TransData Nexus. All rights reserved. This report is provided for informational purposes only.
Data sourced from official customs filings and licensed commercial trade databases.
Reproduction without permission is prohibited.
Explore the full Diphenhydramine product page
Live data, supplier directory, price trends, and trade route analysis